WO2006119087A2 - Photoluminescent silica-based sensors and methods of use - Google Patents
Photoluminescent silica-based sensors and methods of use Download PDFInfo
- Publication number
- WO2006119087A2 WO2006119087A2 PCT/US2006/016389 US2006016389W WO2006119087A2 WO 2006119087 A2 WO2006119087 A2 WO 2006119087A2 US 2006016389 W US2006016389 W US 2006016389W WO 2006119087 A2 WO2006119087 A2 WO 2006119087A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- silica
- dye
- sensor
- dyes
- photoluminescent
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
- G01N2021/6441—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks with two or more labels
Definitions
- the present invention relates to silica-based particles and more particularly to silica-based particles comprising photoluminescent species adapted for use as sensing agents.
- photoluminescent imaging has evolved substantially in recent years, towards high resolution, real time, molecular-level analysis to visualize and understand life and its processes.
- photoluminescence-based assays stems from their excellent contrast, high specificity and fast response times.
- photoluminescent dyes Although the majority of photoluminescent dyes are designed to be insensitive to their surroundings, a variety of dyes have been synthesized with specific affinity and response to chemical analytes or environmental stimuli. Certain types of photoluminescent dyes, for example, have been used free in solution as sensors responsive to chemical analytes or environmental stimuli.
- sensing and insensitive photoluminescent compounds are often used free in solution, in some cases, these dyes have been integrated into sensing platforms such as optical fibers, thin films and membranes.
- the composition of the sensing platform as well as the identity of the photoluminescent dye may impact the properties of the dye in addition to determining the types of unknown conditions subject to investigation its sensing capabilities.
- an environmental or analyte sensor that can optimize the variable properties of photoluminescent dyes and sense unknown conditions in a variety of environments.
- the present invention concerns improved sensor particles for detecting a variety of environmental conditions and analytes.
- the present invention also concerns methods of using these particles in sensing applications.
- the sensor particles of the present invention comprise a core and at least one photoluminescent dye.
- the core is a silica-based nanoparticle and the at least one photoluminescent dye includes a reference dye and a sensor, at least one of which may be covalently bonded to the core.
- the reference dye may be positioned within the core and the sensor dye may be positioned on at least a portion of a surface of the core.
- the reference dye and the sensor dye may be positioned on or over the core.
- the silica-based particle may comprise a silica-based shell surrounding the core, wherein the reference dye is positioned within the core and the silica-based shell is interposed between the reference dye and the sensor dye.
- one of the reference and sensor dyes comprises between about 1.0 and about 1000.0 dye molecules per sensor particle and the reference and sensor dyes emit photons in response to a single or multiple wavelength excitation source.
- the wavelengths of peak emission of the reference and sensor dyes in response to appropriate excitation are typically separated by a sufficient gap to individually discern their emission peaks.
- the core comprises a plurality of pores, at least one of which includes a diameter between about 0.1 nm and about 100.0 nm and more particularly between about 2.0 nm and about 50.0 nm.
- the diameter of the silica-based particle may be between about 1.0 nm. and about 250.0 nm.
- the method comprises the steps of providing at least one silica-based particle comprising two or more photoluminescent dyes, introducing the at least one silica-based particle into an environment comprising an unknown condition or analyte, exposing the at least one silica-based particle to excitation photons, such that each of the two or more photoluminescent dyes emits photons, recording the photons emitted by the two or more photoluminescent dyes, and determining the unknown environmental condition or analyte from these data.
- This method may further comprise excitation of the two or more photoluminescent dyes with photons in the presence of a known environmental condition or analyte and comparing resulting emission waves of the two or more photoluminescent dyes in the presence of the known environmental condition or analyte.
- the emission taken in the presence of the known environmental condition or analyte may be used to generate comparison data, which is correlated to the known condition or analyte.
- the determining step may include using the comparison data to determine the unknown condition or analyte.
- the determining step may also comprise simultaneous interrogation of multiple sensor dyes whose emission peaks may be deconvolved to yield the status of multiple unknown conditions or analytes.
- a method of determining an unknown condition in an organism comprises the steps of providing a silica-based nanoparticle comprising a sensor dye that emits photons, inserting the silica-based nanoparticle into the organism exciting the sensor dye with photons, detecting the photoluminescent emission of the sensor dye, and determining the unknown condition of the organism.
- the sensor dye may emit photons at infrared or near infrared wavelengths.
- the silica-based nanoparticle may be positioned within a cell, tissue, blood or other bodily fluids of the organism.
- Fig. IA is a perspective view of one embodiment of the silica-based particles of the present invention in partial cross-section;
- Fig. IB is a perspective view of another embodiment of the silica-based particles of the present invention in partial cross-section;
- Fig. 1C is a perspective view of yet another embodiment of the silica-based particles of the present invention in partial cross-section
- Fig. ID is a perspective view of yet another embodiment of the silica-based particles of the present invention in partial cross-section
- Fig. 2A is a scanning electron microscope image of the silica-based particles of Fig. IA;
- Fig. 2B is scanning electron microscope image of the silica-based particles of Fig. IB;
- Fig. 2C is scanning electron microscope image of the silica-based particles of Fig. 1C;
- Fig. 3 is a plot of photoluminescent intensity against peak wavelength measurements using the silica-based particles of the present invention in known pH, and
- Fig. 4 is a calibration curve depicting the ratios of peak wavelength emissions for the reference and sensor dyes correlated to pH, based on the data collected in Fig. 3.
- the silica-based particles of the present invention are typically nanoparticles and comprise a silica-based core and two or more photoluminescent dyes.
- the term core means a central or foundational part.
- Silica used for forming the silica-based matrix may include the general formula R 4-0 SiX n , where X can be a hydrolyzable group, such as ethoxy, methoxy or 2-methoxy-ethoxy, R can be an organic group (for example methyl or ethyl) and n is an integer from 1 to 4.
- the two or more photoluminescent dyes comprise a reference dye and a sensor dye.
- the term reference dye means a dye that is substantially insensitive to its environment and/or any analytes present therein or exhibits the same or substantially the same photon emissions upon exposure to excitation photons in different environments.
- the term sensor dye means any dye that is sensitive or responsive to its environment and/or analytes or exhibits different photon emissions upon exposure to photons in different environments or analytes.
- the reference and sensor dyes may be covalently bound to the silica-based matrix.
- the dyes may be incorporated into the silica-based matrix through physical entrapment without covalent linkages or adsorbed onto the surface of the matrix.
- associating the reference and sensor dyes with a silica- based matrix can enhance brightness of the dyes and discourage photobleaching (i.e. the dyes stay brighter longer).
- silica-based particles of the present invention may exhibit enhanced brightness levels as compared to the free dye in solution, as measured, for example, by photoluminescent correlation spectroscopy.
- the silica-based matrix comprises pores or interstices, which allow fluids or analytes to penetrate the silica-based matrix and interact directly with the sensor dye positioned therein. In this way, sensing capability may be enhanced.
- the pores typically include diameters between about 0.1 nanometers and about 100.0 nanometers. Pore size may display a heterogeneous distribution, ranging in size from 2.0 nanometers to about 50 nanometers and up.
- a silica-based matrix enables excitation of two or more dyes with a single excitation wavelength.
- varying the number of molecules of each dye per particle may allow dye combinations that normally require multiple excitation wavelengths to respond to a single excitation wavelength.
- additional reference dye molecules may be associated with the silica-based matrix to increase its relative absorption, so that both dyes respond measurably to the same excitation wavelength.
- the silica-based matrix can incorporate between about 1.0 and about 1000.0 dye molecules per particle, with between 2.0 and 100.0 dye molecules being typical.
- the silica-based matrix may include more than one sensor dye for sensing more than one environmental condition or analyte. Assuming that the emission wavelengths of the incorporated dyes are far enough apart to discern separate emission peaks, between about one and about seven and more particularly between about two and five distinct sensor dyes may be associated with the silica- based matrix for separate sensing applications.
- Silica-based particles of the present invention may also incorporate additives.
- a core of superparamagnetic material such as nano-sized iron oxide or other magnetic alloys or oxides and/or one or more of a multitude of functional groups may be positioned on particle surfaces for various purposes.
- the particles can be conjugated with antibodies or therapeutic agents to identify and treat disease states or conditions.
- the therapeutic agent can be absorbed into the pores of the silica-based matrix or coated on a surface of the particles.
- the surface of the final silica-based particles can be functionalized with a wide variety of surface modifiers, including amines, antibodies, microorganisms, viruses, enzymes, receptors, haptens, hormones, or combinations thereof.
- amine groups such as aminopropyl and methylaminopropyl groups
- alkyl groups such as methyl or dodecyl chains
- functional silica-conjugated groups are available to react with a variety of species, including polymers for example: polyethylene glycol (PEG), cross-linkers and other surface modifiers, such as carboxylic acids, esters or biotin, which may be used to attach other moeties to the particle surface, including peptides, DNA, antibodies and avidin/streptavadin.
- the surface modifier can comprise a layer surrounding the particle, which is selectively permeable to certain analytes.
- the layer is interposed between the sensor dye and the environment.
- Functionalizing the surface of the particles with the appropriate surface modifier may also allow use of the particles in a multitude of target environments. For example, the addition of a hydrophobic coating allows the particles to be dispersed in a hydrophobic environment.
- selection of the appropriate surface modifier can lead to preferential interaction, defined as a relative increase in the likelihood of a particular desired interaction. Examples include functionalization of particle surfaces with at least one antibody having an affinity for antigens on cell surfaces and/or use of a coating comprising biotin and avadin/streptavadin, which preferentially interacts with biotin in target environments.
- the two or more photoluminescent dyes may comprise a reference dye and a sensor dye.
- the peak emission wavelengths of the reference and sensor dyes are typically separated by a sufficient wavelength gap to individually discern their peaks upon excitation at the same wavelength.
- the reference dye is typically sequestered within the silica-based particle, usually in its core. Although the reference dye is substantially insensitive to its environment and analytes, sequestering the reference dye within the particle serves as a precautionary measure to avoid interaction with the target environment or analyte, to the extent some sensitivity does exist.
- Suitable reference dyes include, but are not limited to, the following:
- So-called MegaStokes TM dyes are defined here as dyes that exhibit differences between their excitation and emission wavelengths between about 30.0 nm to about 200.0 nm.
- the sensor dye is typically placed at or near a surface of the silica-based particle to increase its interaction with the environment and/or any analytes. Under this construction, the sensor dye is more likely to come into direct contact with the environmental condition or analyte undergoing investigation. Emissions of sensor dyes are subject to environmental or analyte stimuli. Depending on pH of the environment, pH sensor dyes, for example, exhibit varying emission spectra based on changes in the sensor dye's electronic state, through the addition or subtraction of protons. The presence of metal ions may cause diminished emissions by quenching the sensor dye.
- Resoruf ⁇ n ethers (benzyl, Enzyme 560/580 Physical Entrapment Visible ethyl, methyl, etc.) Activity + pH Lifetime
- Caged dyes are a class of photoluminescent dyes whose photoluminescent state is activated by their environment. In other words, caged dyes enter their working environment in a non- photoluminescent state and are turned "on" by external events that modify the chemical structure of the dye.
- Caged dyes typically comprise a covalent attachment of particular groups to a main conjugated ring structure. Activation may occur when the covalent attachment is cleaved due to environmental stimuli. For example, resorufin (7-hydroxy-3H-phnoxazin-3-one) is the parent dye of a family of caged dyes that utilize a cleavable ether attachment.
- the dyes may be incorporated into a silica-based matrix in various configurations.
- the silica-based particles include an internal core 10 comprising a silica-based matrix and the reference dye, an intermediate silica-based shell 12, and an external shell 14 comprising the sensor dye.
- the intermediate silica-based shell is interposed between the reference and sensor dyes.
- the intermediate silica-based shell may solely comprise a silica-based material without the presence of photoluminescent dye or in the presence of minimal photoluminescent dye (e.g., less than 5% by weight).
- the silica-based particles include an internal core, 10, comprising a silica-based matrix and the reference dye and an external shell 14 comprising the sensor dye.
- the silica- based particles comprise an internal core 10 comprising a silica-based matrix, a first shell 16 comprising the reference dye and a second shell 14 surrounding the first shell and comprising the sensor dye.
- the silica-based particles include an internal core 10, comprising a silica-based matrix, a first shell 16 comprising the reference dye, an intermediate shell 12 surrounding the first shell and comprising another silica-based matrix and an outer shell 14 surrounding the inner shells and comprising the sensor dye.
- the diameter of the core may be between about 2.0 nanometers and tens of microns and typically between about 25.0 nanometers and 200.0 nanometers.
- the thickness of the first and subsequent shells may be between about 1.0 nanometer to about 400.0 nanometers and typically between about 10.0 nanometers to about 50.0 nanometers.
- the first and subsequent shells may cover from about 10.0 percent to about 100.0 percent of the surface area of the particles.
- the size of the particles may be between about 10.0 run and tens of microns, and more particularly between about 10.0 nm and about 1.0 micron.
- the particles may, for example, be created using the sol-gel process.
- Sol-gel chemistry allows the synthesis of silica-based particles under benign conditions, such as room temperature and without the use of harmful chemicals.
- reverse micelles may be employed as reactors for particle synthesis.
- Reverse micelles are stable suspensions of a polar aqueous phase within a hydrophobic solvent, mediated by amphiphilic surfactant molecules.
- the St ⁇ ber sol-gel process typically yields silica-based particles that include covalent linkages to the reference and sensor dyes.
- silica-based particles of the present invention can be prepared through the Stober sol-gel process by mixing a reactive reference dye with a co-reactive organosilane compound to form a reactive photoluminescent organosilane compound that can be co-condensed to form a core, followed by conjugation of a sensor dye to the core by mixing the core particle with the sensor dye and additional co-reactive organo/alkoxysilanes.
- the sol-gel process may, however, be modified depending on the desired architecture of the particles.
- the silica-based particles of the present invention may exhibit various configurations, including an internal core comprising a silica-based matrix and a reference dye and an external shell comprising a sensor dye (Figs. IA and IB) and an internal core comprising a silica-based matrix, a first shell comprising the reference dye and an outer shell surrounding the first shell and comprising the sensor dye (Fig. 1C and ID).
- Preparation of the silica-based particles of Figs. IA comprises synthesis of the core, subsequent growth of a silica intermediate shell and formation of the sensor dye- rich silica shell. Synthesis of the core typically occurs in three steps. First, in an inert gas atmosphere, a silane compound is coupled to the reference dye at a mole ratio of silane to reference dye of about 50:1 in degassed ethanol to form a photoluminescent silane compound. This product - the reference dye conjugate - is then added under ambient conditions to an absolute ethanolic solution of ammonia and water, under vigorous stirring.
- a silica precursor such as tetraethoxysilane, is then promptly added to yield a final reaction solution of reference dye conjugate, silica precursor, ammonia and water in concentrations of 1.7xlO "5 M, 0.05 M, 0.2 M and 0.855 M.
- This reaction proceeds for 12-18 hrs and produces dye-rich silicate cores, with diameters of about 5.0 nanometers.
- additional silica precursor is slowly added to grow a silica shell, in an amount of about 5.55xlO "6 M per minute, to reach a final reaction condition of reference dye conjugate, silica precursor, ammonia and water of 1.7xlO "5 M, 1.055 M, 0.5 M and 0.855 M.
- the particles are dialyzed once against ethanol for approximately 24 hours.
- the dialyzed solution is then diluted to avoid agglomeration of the particles during the sensor dye coupling reaction.
- the sensor dye is conjugated to the silane in a similar manner as above for the reference dye to form sensor dye conjugate, though in this case the molar ratio is much lower ⁇ i.e., 2:1 molar ratio of silane to sensor dye), to avoid excess animation of the particles during functionalization. This serves the dual purposes of avoiding agglomeration of particles and helping to prevent amines on the surface from inhibiting the sensor dye's ability to sense.
- the sensor dye conjugate is mixed with a silica precursor in ethanol at a molar ratio of sensor dye conjugate to silica precursor of about 1.2xlO "5 M to 0.0125 M.
- This mixture is added drop-wise to the dialyzed solution of core/shell particles. After the solution is allowed to react, it is dialyzed against absolute ethanol, where it remains stable for at least several months without agglomeration.
- the final particles shown in a scanning electron microscope at Fig. 2A are approximately 40.0 nanometers in diameter.
- the size of the core as well as the size of the particles made with the sol-gel process can be altered.
- the synthesis that leads to the particle architecture shown in Fig IB follows. Silica and a reference dye conjugate, per above, are co-condensed in an ethalonic solution at concentrations of 2.13xlO "5 M reference dye conjugate, 0.2 M silica precursor, 0.625 M ammonia and 1.45 M water to yield monodisperse core particles of about 55.0 nanometers in diameter.
- sensor dye conjugate and additional silica precursor are added drop wise to yield a final reaction condition of 2.13xlO "5 M reference dye conjugate, 2.13xlO "5 M sensor dye conjugate, 0.254M silica precursor, 0.625 M ammonia and 1.45 M water.
- These particles which lack an intermediate silica shell between the core and the sensor dye-containing outer shell, are then centrifuged and re-suspended twice in ethanol and twice in water to remove excess reagents. As shown in Fig. 2B, the final particles are approximately 60.0 to 80.0 nanometers in size and comprise a relatively large reference dye-rich core and a sensor dye-rich shell.
- silica particle architecture shown in Fig. 1C entails slight modifications to foregoing processes.
- Silica precursor, ammonia and water at ratios of 0.17 M to 1.0M to 2.5M are combined in absolute ethanol under ambient conditions, with vigorous stirring. After the solution reacts, the reaction product is collected by centrifiigation and re-suspended by ultrasonication with water and ethanol.
- the seed particles comprised of silica
- the seed particles are then re-suspended in absolute ethanol with water and ammonia, followed by drop-wise addition of a pre-combined solution of silica precursor, reference conjugate and ethanol to yield a final reaction condition of reference conjugate, silica precursor, ammonia and water of 1.16M, 0.027M, 0.2M, and 2.0M, respectively.
- the particles are centrifuged and washed repeatedly with absolute ethanol and deionized water.
- a similar synthesis was preformed to create a sensor dye shell on these particles, using a sensor dye conjugate synthesized in ethanol under inert atmosphere and a 50.0 to 1.0 molar ratio of organosilane to sensor dye.
- the final particles are approximately 200.0 nanometers in size and comprise a silica-rich core surrounded by a first reference dye rich shell surrounded by a second sensor dye rich shell.
- Fig. ID an intermediate silica shell, between the reference and sensing dye layers is introduced by condensing pure silica precursors onto the first shell to ensure further protection of the encapsulated reference dye.
- a microemulsion synthesis protocol is followed. Silica-based seed particles, with reference dye, are first synthesized using the St ⁇ ber sol-gel process.
- seed particles are transferred from ethanol into an aqueous environment via dialysis or centrifugation and washing.
- the reactive concentrations required for sufficient surface coating are calculated based on the number of available surface silanol groups which is dependent upon particle size as well as concentration.
- the particles and any dextran- bound or otherwise hydrophilic dyes are added in aqueous solution into a reverse microemulsion formed in cyclohexane in the presence of a charged or uncharged amphiphilic surfactant with or without co-surfactants, as needed.
- a concentrated solution of ammonia is added to catalyze condensation of a silica precursor, which is added last.
- One suitable surfactant/co-surfactant combination is Triton X-100® and n- hexanol.
- a coating of about 2.0 to about 10.0 nanometers in thickness may be effectively attached to the particle surface in the presence of free dye molecules or dextran-bound dyes, which become trapped in the silica matrix as it forms, thus encapsulating the sensor dye molecules and creating a particle based sensor.
- the photoluminescent dyes are typically physically entrapped or entrained in the silica- based matrix.
- silica-based particles of the present invention may be used for sensing in both biological and non-biological systems.
- sensing methodologies including ratiometric sensing, spectral shift sensing and lifetime sensing are possible.
- the silica-based particles may be introduced into cells, cell membranes, tissues, prokaryotic systems ⁇ e.g., E. coli biofilms), solutions, reactions and bodies of water, like rivers and lakes.
- Several methods exist for introducing the silica-based particles into cells including commercially available lipid vesicle based methods, microinjection, and antibody- specific uptake (during which a cell surface receptor mediates endocytosis of the particle). In phagocytic cells and some endocytic cells, uptake may occur spontaneously. Based on the brightness levels exhibited by the particles, measurements may advantageously be taken through incorporation of only a single silica-based particle of the present invention into the target environment. Multiple silica-based particles may, however, be employed.
- silica-based particles may also be employed as sensors in various organisms, on animal cells or bodily fluids, including human cells or bodily fluids, such as blood or serum. Cells or fluids may be harvested and tested outside the body or a whole body imager may excite the dyes within the body and measure emission.
- In vitro sensing typically relies upon sensors comprising photoluminescent dyes in the visible spectrum. With in vivo testing, the sensors may be locally injected into a particular area or functionalized with antibodies that exhibit preferential interactions with certain cell surface receptors. Sensor dyes used for in vivo testing typically exhibit infrared or near infrared emission wavelengths.
- the environmental conditions or analytes undergoing sensing may also vary.
- Environmental conditions like pH levels and hydrophobic or hydrophilic states may be determined.
- the presence and concentration of ions such as potassium, phosphate, sodium, calcium, copper, magnesium, chromium, chloride, fluoride and iron, heavy metals, such as cadmium, zinc, lead, selenium, mercury, nickel, as well as biomolecular substances, such as vitamins and amino acids, may also be evaluated.
- in vitro and in vivo testing with the silica-based particles of the present invention may advantageously be employed for ascertaining the redox status of cells within the body of a living organism.
- the redox status of a cell describes its oxidation- reduction potential (i.e., the potential of the cell to lose electrons (oxidation) versus its potential to gain electrons (reduction)).
- the energy on which cells rely is derived mainly from energy released through oxidation from organic molecules to oxygen, yielding an overall reducing environment within cells, which is carefully regulated.
- Externally or internally opposed challenges to the normal oxidative/reductive balance - redox stresses - have been shown to be indicative of negative cellular events, specifically tumorigenesis, and may be important in disease or injury states such as cancer and strokes.
- Ratiometric sensing means the determination of unknown environmental conditions based on ratios established for and corresponding to known environmental conditions.
- Major emission peak intensities of two or more photoluminescent dyes are measured under known environmental or analyte conditions.
- a calibration is perfo ⁇ ned by calculating ratios of peak emission for the two dyes (sensor dye/reference dye); the ratios correspond to known conditions.
- the calibration forms a basis for determinations of unknown conditions through excitation and emission intensity measurement of particles comprising the same reference and sensor dyes under the unknown condition.
- Spectral-shift based measurements operate under similar principles. Unknown environmental or analyte conditions are investigated through the use of calibration curves that are established based on the wavelengths of maximal emission exhibited by reference and sensor dyes upon excitation under known conditions. Rather than relying upon ratios of peak emission intensities, however, the difference between maximum peak wavelengths ( ⁇ max ) for the reference and sensor dyes is used as the dependent variable.
- Lifetime-based sensing measures the excited state lifetimes of two or more photoluminescent dyes, one of which whose lifetime is known to be environmentally insensitive, and at least one of which whose lifetime is dependent upon a specific environmental condition or analyte.
- the fluorescence lifetime ( ⁇ ) is the length of time that a photoluminescent dye spends in an excited state, from initial absorption of a photon until its emission; it is most often in the range from 10 ps to several nanoseconds.
- a calibration may be performed by measurement of the fluorescence lifetimes for multiple analyte concentrations, creating a basis for further concentration determinations.
- one or more particles are first introduced into an environment having known conditions.
- the particles are then excited by one or more selected wavelengths of a multi-photon light source, typically exhibiting an excitation wavelength between about 250.0 nm and about 800.0 nm, as appropriate for the absorption profiles of the reference and sensor dyes in the particle.
- Multiphoton excitation utilizes lasers (often Ti-Sapphire), which can be tuned to a variety of emission wavelengths.
- the long wavelength (700.0 nm to >1500.0 nm) photons are not readily absorbed by tissue or media but may induce multiphoton excitation in dye molecules at very high photon flux ⁇ i.e., at the focal point of the beam).
- the reference dye typically exhibits a relatively constant wavelength and intensity of emission
- the sensor dye exhibits emissions that correspond to environmental stimuli or to the presence or concentration of certain analytes.
- photon emissions may be measured. Measurement may be carried out using spectrofluorometry or fluorescence microscopy.
- Photoluminescent lifetime is measured using a pulsed laser source and a gated detector which measures the emission as a function of time following irradiation. Photoluminescent emission is collected in quartz or plastic cuvettes as a function of emission wavelength at 90 degrees to the excitation beam via photon counting on a photomultiplier tube or avalanche photodiode.
- comparison data After the comparison data have been generated, they may be used to ascertain unknown environmental conditions or the presence and concentration of analytes. Particle emissions are recorded in the presence of the unknown condition or analyte, and the data are used to determine the unknown condition by comparing it with the comparison data established for the known conditions.
- silica-based particles of the present invention can be used in a variety of other applications, such as those disclosed in co-owned co-pending U.S. App. Serial No. 10/306,614, entitled “Fluorescent Silica Based Nanoparticles.” All uses disclosed therein are hereby incorporated by reference.
- a 200.0 nanometer silica-based particle comprising a reference dye and a sensor dye based upon the architecture shown in Figure 1C was synthesized for use as a ratiometric sensor to detect environmental pH.
- the particles were resuspended at 0.787 mg/ml in absolute ethanol with appropriate water and NH 3 concentrations and a pre-combined solution of TEOS, TRITC-conjugate and ethanol was added drop wise (7.5 x 10 "7 M ⁇ E ⁇ s/n ⁇ i) to yield a final reaction condition of [TRITC-conjugate], [TEOS], [NH 3 ] and [H 2 O] of 1.16mM, 0.2 7M, 0.2 M and 2.0 M. Following reaction for 12-18 hours, the particles were centrifuged and washed repeatedly with absolute ethanol and deionized water.
- the particles were diluted from deionized water into sodium phosphate buffers between pH 5 and 9 at 3:20 (v/v) dilutions.
- the particles were then excited through introduction of a single photon light source at 540.0 nm to excite the tetramethylrhodamine and 490.0 nm to excite the fluorescein.
- the emission wavelengths were measured by spectrofluorometry (with a Photon Technologies International Spectrofluorometer); maximum peaks are shown in Fig. 3. The larger wavelength peaks correspond to the fluorescein sensor dye while the smaller peaks correspond to the tetramethylrhodamine reference dye.
- the calibration curves provide linear calibration over the range of pH from 5-9 for each set of tested particles.
- the silica-based particles synthesized above may be introduced into a solution of unknown pH.
- the particles may be excited with the same single photon light source used during calibration at the same excitation wavelengths.
Abstract
Sensor particles comprise a silica-based core and at least one photoluminescent dye. The silica-based core may comprise a plurality of pores and the at least one photoluminescent dye may comprise a reference dye, insensitive to its environment and analytes and a sensor dye, sensitive to either or both of the foregoing. The sensor particles may be employed to sense unknown environmental conditions or analytes in biological or non-biological systems, in vitro or in vivo.
Description
APPLICATIONFOR
UNITED STATES LETTERS PATENT
FOR
PHOTOLUMINESCENT SILICA-BASED SENSORS AND METHODS OF USE
SPECIFICATION
To Whom It May Concern:
Be it known that we, Andrew A. Bums, Erik Herz and Tara C. Zedayko, all citizens of the United States of America and residents of Ithaca, New York and Ulrich Wiesner, a citizen of Geπnany and a resident of Ithaca, New York, have invented certain new and useful compositions and methods in:
PHOTOLUMINESCENT SILICA-BASED SENSORS AND METHODS OF USE, OF WHICH THE FOLLOWING IS A SPECIFICATION:
Field of Invention
The present invention relates to silica-based particles and more particularly to silica-based particles comprising photoluminescent species adapted for use as sensing agents.
Background The technology behind photoluminescent imaging has evolved substantially in recent years, towards high resolution, real time, molecular-level analysis to visualize and understand life and its processes. The appeal of photoluminescence-based assays stems from their excellent contrast, high specificity and fast response times.
Although the majority of photoluminescent dyes are designed to be insensitive to their surroundings, a variety of dyes have been synthesized with specific affinity and response to chemical analytes or environmental stimuli. Certain types of photoluminescent dyes, for example, have been used free in solution as sensors responsive to chemical analytes or environmental stimuli.
Although both sensing and insensitive photoluminescent compounds are often used free in solution, in some cases, these dyes have been integrated into sensing platforms such as optical fibers, thin films and membranes. The composition of the sensing platform as well as the identity of the photoluminescent dye may impact the properties of the dye in addition to determining the types of unknown conditions subject to investigation its sensing capabilities. There is a need for an environmental or analyte sensor that can optimize the variable properties of photoluminescent dyes and sense unknown conditions in a variety of environments.
Summary of Invention
The present invention concerns improved sensor particles for detecting a variety of environmental conditions and analytes. The present invention also concerns methods of using these particles in sensing applications.
Briefly, the sensor particles of the present invention comprise a core and at least one photoluminescent dye.
In certain embodiments, the core is a silica-based nanoparticle and the at least one photoluminescent dye includes a reference dye and a sensor, at least one of which may be covalently bonded to the core. The reference dye may be positioned within the core and the sensor dye may be positioned on at least a portion of a surface of the core. Alternatively, the reference dye and the sensor dye may be positioned on or over the core. Further, the silica-based particle may comprise a silica-based shell surrounding the core, wherein the reference dye is positioned within the core and the silica-based shell is interposed between the reference dye and the sensor dye. In other embodiments, one of the reference and sensor dyes comprises between about 1.0 and about 1000.0 dye molecules per sensor particle and the reference and sensor dyes emit photons in response to a single or multiple wavelength excitation source. The wavelengths of peak emission of the reference and sensor dyes in response to appropriate excitation are typically separated by a sufficient gap to individually discern their emission peaks. In still other embodiments, the core comprises a plurality of pores, at least one of which includes a diameter between about 0.1 nm and about 100.0 nm and more particularly between about 2.0 nm and about 50.0 nm. The diameter of the silica-based particle may be between about 1.0 nm. and about 250.0 nm.
Methods of the present invention comprise use of the sensor particles to sense unknown environmental conditions or analytes.
In one embodiment, the method comprises the steps of providing at least one silica-based particle comprising two or more photoluminescent dyes, introducing the at least one silica-based particle into an environment comprising an unknown condition or analyte, exposing the at least one silica-based particle to excitation photons, such that each of the two or more photoluminescent dyes emits photons, recording the photons emitted by the two or more photoluminescent dyes, and determining the unknown environmental condition or analyte from these data. This method may further comprise excitation of the two or more photoluminescent dyes with photons in the presence of a known environmental condition or analyte and comparing resulting emission waves of the two or more photoluminescent dyes in the presence of the known environmental condition or analyte. Under these circumstances, the emission taken in the presence of the known environmental condition or analyte may be used to generate comparison data, which is correlated to the known condition or analyte. Thus, the determining step may include using the comparison data to determine the unknown condition or analyte. The determining step may also comprise simultaneous interrogation of multiple sensor dyes whose emission peaks may be deconvolved to yield the status of multiple unknown conditions or analytes.
In another embodiment, a method of determining an unknown condition in an organism comprises the steps of providing a silica-based nanoparticle comprising a sensor dye that emits photons, inserting the silica-based nanoparticle into the organism exciting the sensor dye with photons, detecting the photoluminescent emission of the sensor dye, and determining the unknown condition of the organism. The sensor dye may emit photons at infrared or near infrared wavelengths. The silica-based
nanoparticle may be positioned within a cell, tissue, blood or other bodily fluids of the organism.
Brief Description of the Drawings
Certain embodiments of the presently claimed invention are illustrated by the accompanying figures. It should be understood that the figures are not necessarily to scale and that details that are not necessary for an understanding of the invention or which render other details difficult to perceive may be omitted. It should be understood, of course, that the invention is not necessarily limited to the particular embodiments illustrated herein.
Fig. IA is a perspective view of one embodiment of the silica-based particles of the present invention in partial cross-section;
Fig. IB is a perspective view of another embodiment of the silica-based particles of the present invention in partial cross-section;
Fig. 1C is a perspective view of yet another embodiment of the silica-based particles of the present invention in partial cross-section; Fig. ID is a perspective view of yet another embodiment of the silica-based particles of the present invention in partial cross-section;
Fig. 2A is a scanning electron microscope image of the silica-based particles of Fig. IA;
Fig. 2B is scanning electron microscope image of the silica-based particles of Fig. IB;
Fig. 2C is scanning electron microscope image of the silica-based particles of Fig. 1C;
Fig. 3 is a plot of photoluminescent intensity against peak wavelength measurements using the silica-based particles of the present invention in known pH, and
Fig. 4 is a calibration curve depicting the ratios of peak wavelength emissions for the reference and sensor dyes correlated to pH, based on the data collected in Fig. 3.
Detailed Description
The silica-based particles of the present invention are typically nanoparticles and comprise a silica-based core and two or more photoluminescent dyes. As used herein, the term core means a central or foundational part. Silica used for forming the silica-based matrix may include the general formula R4-0SiXn , where X can be a hydrolyzable group, such as ethoxy, methoxy or 2-methoxy-ethoxy, R can be an organic group (for example methyl or ethyl) and n is an integer from 1 to 4. The two or more photoluminescent dyes comprise a reference dye and a sensor dye. As used herein, the term reference dye means a dye that is substantially insensitive to its environment and/or any analytes present therein or exhibits the same or substantially the same photon emissions upon exposure to excitation photons in different environments. The term sensor dye means any dye that is sensitive or responsive to its environment and/or analytes or exhibits different photon emissions upon exposure to photons in different environments or analytes. In certain embodiments, the reference and sensor dyes may be covalently bound to the silica-based matrix. In other embodiments, the dyes may be incorporated into the silica-based matrix through physical entrapment without covalent linkages or adsorbed onto the surface of the matrix.
In one embodiment, associating the reference and sensor dyes with a silica- based matrix can enhance brightness of the dyes and discourage photobleaching (i.e. the dyes stay brighter longer). In these embodiments, silica-based particles of the present invention may exhibit enhanced brightness levels as compared to the free dye in solution, as measured, for example, by photoluminescent correlation spectroscopy. In another embodiment, the silica-based matrix comprises pores or interstices, which allow fluids or analytes to penetrate the silica-based matrix and interact directly with the sensor dye positioned therein. In this way, sensing capability may be enhanced. The pores typically include diameters between about 0.1 nanometers and about 100.0 nanometers. Pore size may display a heterogeneous distribution, ranging in size from 2.0 nanometers to about 50 nanometers and up.
In another embodiment, use of a silica-based matrix enables excitation of two or more dyes with a single excitation wavelength. For reference and sensor dyes which exhibit discernable emission peaks, varying the number of molecules of each dye per particle may allow dye combinations that normally require multiple excitation wavelengths to respond to a single excitation wavelength. For instance, if the reference dye requires a longer excitation wavelength than the sensor dye for emission, additional reference dye molecules may be associated with the silica-based matrix to increase its relative absorption, so that both dyes respond measurably to the same excitation wavelength. The silica-based matrix can incorporate between about 1.0 and about 1000.0 dye molecules per particle, with between 2.0 and 100.0 dye molecules being typical.
In yet another embodiment, the silica-based matrix may include more than one sensor dye for sensing more than one environmental condition or analyte. Assuming that the emission wavelengths of the incorporated dyes are far enough apart to discern
separate emission peaks, between about one and about seven and more particularly between about two and five distinct sensor dyes may be associated with the silica- based matrix for separate sensing applications.
Silica-based particles of the present invention may also incorporate additives. A core of superparamagnetic material, such as nano-sized iron oxide or other magnetic alloys or oxides and/or one or more of a multitude of functional groups may be positioned on particle surfaces for various purposes. For example, the particles can be conjugated with antibodies or therapeutic agents to identify and treat disease states or conditions. The therapeutic agent can be absorbed into the pores of the silica-based matrix or coated on a surface of the particles. The surface of the final silica-based particles can be functionalized with a wide variety of surface modifiers, including amines, antibodies, microorganisms, viruses, enzymes, receptors, haptens, hormones, or combinations thereof. The use of amine groups, such as aminopropyl and methylaminopropyl groups, creates positive surface charges which are attracted to the negative charge of a cell surface. The use of alkyl groups, such as methyl or dodecyl chains, creates a non-charged surface, allowing the particles to exist in hydrophobic environments - within a cell membrane for example. Further, functional silica-conjugated groups are available to react with a variety of species, including polymers for example: polyethylene glycol (PEG), cross-linkers and other surface modifiers, such as carboxylic acids, esters or biotin, which may be used to attach other moeties to the particle surface, including peptides, DNA, antibodies and avidin/streptavadin. The surface modifier can comprise a layer surrounding the particle, which is selectively permeable to certain analytes. The layer is interposed between the sensor dye and the environment.
Functionalizing the surface of the particles with the appropriate surface modifier may also allow use of the particles in a multitude of target environments. For example, the addition of a hydrophobic coating allows the particles to be dispersed in a hydrophobic environment. Along these lines, selection of the appropriate surface modifier can lead to preferential interaction, defined as a relative increase in the likelihood of a particular desired interaction. Examples include functionalization of particle surfaces with at least one antibody having an affinity for antigens on cell surfaces and/or use of a coating comprising biotin and avadin/streptavadin, which preferentially interacts with biotin in target environments.
As previously mentioned, the two or more photoluminescent dyes may comprise a reference dye and a sensor dye. The peak emission wavelengths of the reference and sensor dyes are typically separated by a sufficient wavelength gap to individually discern their peaks upon excitation at the same wavelength.
The reference dye is typically sequestered within the silica-based particle, usually in its core. Although the reference dye is substantially insensitive to its environment and analytes, sequestering the reference dye within the particle serves as a precautionary measure to avoid interaction with the target environment or analyte, to the extent some sensitivity does exist. Suitable reference dyes include, but are not limited to, the following:
Reference Dye Name Integration λeχ/λem(nm) Emission Method
Dyomics DY 615 621/641 NHS Ester Visible
Molecular Probes AlexaFluor 647 651/672 NHS Ester Visible
Dyomics DY 675 674/699 NHS Ester Near IR
Dyomics DY 700 702/723 NHS Ester Near IR
Dyomics DY 731 736/759 NHS Ester Near IR
Dyomics DY 776 771/801 NHS Ester Near IR
Sigma Aldrich NIR 797 795/835 Isothiocyanate Near IR
Dyomics DY 485 XL 488/560 NHS Ester MegaStokes ™
Dyomics DY 510 XL 488/630 NHS Ester MegaStokes ™
So-called MegaStokes ™ dyes are defined here as dyes that exhibit differences between their excitation and emission wavelengths between about 30.0 nm to about 200.0 nm.
The sensor dye is typically placed at or near a surface of the silica-based particle to increase its interaction with the environment and/or any analytes. Under this construction, the sensor dye is more likely to come into direct contact with the environmental condition or analyte undergoing investigation. Emissions of sensor dyes are subject to environmental or analyte stimuli. Depending on pH of the environment, pH sensor dyes, for example, exhibit varying emission spectra based on changes in the sensor dye's electronic state, through the addition or subtraction of protons. The presence of metal ions may cause diminished emissions by quenching the sensor dye.
The following table is a non-exhaustive list of a number of suitable sensor dyes as well as their environmental or analyte sensitivities.
Sensor Dye Name λCχ/λem(nin) Sensitivity Integration Method Emission
Fluorescein Isothiocyanate 485/500 pH (pKa = Amine Conjugation Visible 6.4) β-5-carboxyfluorescein- Caged bis-(5- carboxymethoxy-2-
490/520 Fluorophore Amine Conjugation Visible nitrobenzyl) ether-alanine- + pH carboxamide, succinimidyl
ester
Fluo-4 Iodoacetamide 494/516 Ca+2 Thiol Conjugation Visible
5-carboxy-2',7'- 500/530 pH (pKa = Amine Conjugation Visible dichlorosulfonefluorescein 6.4)
Carboxy 510- Spectral Shift
Amine Conjugation Visible
S eminaphthofluorescein 575/545- pH (pKa
(SNAFL-I) NHS ester 636 =7.7)
Oregon Green 514 pH (pKa =
511/530 Amine Conjugation Visible Carboxylic Acid, NHS 4.6) ester
Erythrosin B 530/555 Oxygen Amine Conjugation Visible Isothiocyanate
Sigma Aldrich NIR667- 667/685 Amino Acids Amine Conjugation Near IR NHS pH (pKa =
Fluorescein 485/500 Dextran-bound Visible 6.4)
Fluo-4 488/530 Ca +2 Dextran-bound Visible Calcium Green 488/535 Ca +2 Dextran-bound Visible pH (pKa =
2 ',7 ' -bis-(2-carboxyethyl)- 488/535 Dextran-bound Visible 7.0) (5/6)-carboxyfluorescein
Spectral Shift
Seminapthorhodafluor- 1 514/560- Dextran-bound Near IR pH (pKa = (SNARF-I) 640
7.5)
4',5'-dichloro-2',7'- 520/550 pH (pKa = Dextran-bound Visible dimethoxyfluorescein 6.4)
575/620
X-Rhod Ca +2 Dextran-bound Visible
PBFI (spectral Shift) 338/557- K+ Physical Entrapment Mega 507 Stokes
6-methoxy-N-(3 - 344/443 Cl" Physical Entrapment Near UV sulfopropyl)quinolinium)
364/385
Zinquin Ethyl Ester Zn +2 Physical Entrapment Near UV
Diaminonapthalene 370/440 Nitric Oxide Physical Entrapment Visible
Calcium Yellow 435/550 Ca +2 Physical Entrapment Visible
4,5 - Diaminofluorescein 488/530 Nitric Oxide Physical Entrapment Visible
4-amino-5-methylamino- 488/525 Nitric Oxide Physical Entrapment Visible 2',7'- difluorofluorescein
Calcium Green 490/540 Ca +2 Physical Entrapment Visible
Magnesium Green 490/540 Mg ~+" 2 Physical Entrapment Visible Dihydrorhodamine 500/536 Nitric Oxide Physical Entrapment Visible
Calcium Orange 540/580 Ca +2 Physical Entrapment Visible
CoroNa Red 547/576 Na+ Physical Entrapment Visible
RhodZin-3 550/575 Zn +2 Physical Entrapment Visible
Resorufϊn ethers (benzyl, Enzyme 560/580 Physical Entrapment Visible ethyl, methyl, etc.) Activity + pH Lifetime
Sulforhodamineamidoethyl
561/581 mercaptan Selenium Physical Entrapment Visible
Boron dipyrromethane(BODIPY Reactive Physical Entrapment Near IR 665/676 665-676) Oxygen
So-called caged dyes may be employed as the sensor dye. Caged dyes are a class of photoluminescent dyes whose photoluminescent state is activated by their environment. In other words, caged dyes enter their working environment in a non- photoluminescent state and are turned "on" by external events that modify the chemical structure of the dye. Caged dyes typically comprise a covalent attachment of
particular groups to a main conjugated ring structure. Activation may occur when the covalent attachment is cleaved due to environmental stimuli. For example, resorufin (7-hydroxy-3H-phnoxazin-3-one) is the parent dye of a family of caged dyes that utilize a cleavable ether attachment.
The dyes may be incorporated into a silica-based matrix in various configurations. Referring now to Figs. IA, IB, 1C and ID, different architectures for the silica-based particles of the present invention are shown. As seen in Fig. IA, the silica-based particles include an internal core 10 comprising a silica-based matrix and the reference dye, an intermediate silica-based shell 12, and an external shell 14 comprising the sensor dye. In this embodiment, the intermediate silica-based shell is interposed between the reference and sensor dyes. The intermediate silica-based shell may solely comprise a silica-based material without the presence of photoluminescent dye or in the presence of minimal photoluminescent dye (e.g., less than 5% by weight). As seen in Fig. IB, the silica-based particles include an internal core, 10, comprising a silica-based matrix and the reference dye and an external shell 14 comprising the sensor dye. As seen in Fig. 1C, the silica- based particles comprise an internal core 10 comprising a silica-based matrix, a first shell 16 comprising the reference dye and a second shell 14 surrounding the first shell and comprising the sensor dye. As seen in Fig ID, the silica-based particles include an internal core 10, comprising a silica-based matrix, a first shell 16 comprising the reference dye, an intermediate shell 12 surrounding the first shell and comprising another silica-based matrix and an outer shell 14 surrounding the inner shells and comprising the sensor dye. In these embodiments, the diameter of the core may be between about 2.0 nanometers and tens of microns and typically between about 25.0 nanometers and 200.0 nanometers. The thickness of the first and subsequent shells may be between about 1.0 nanometer to
about 400.0 nanometers and typically between about 10.0 nanometers to about 50.0 nanometers. The first and subsequent shells may cover from about 10.0 percent to about 100.0 percent of the surface area of the particles. Thus, the size of the particles may be between about 10.0 run and tens of microns, and more particularly between about 10.0 nm and about 1.0 micron. There are a number of ways to synthesize the silica-based particles of the present invention. The particles may, for example, be created using the sol-gel process. Sol-gel chemistry allows the synthesis of silica-based particles under benign conditions, such as room temperature and without the use of harmful chemicals. Alternatively, reverse micelles may be employed as reactors for particle synthesis. Reverse micelles are stable suspensions of a polar aqueous phase within a hydrophobic solvent, mediated by amphiphilic surfactant molecules.
The Stδber sol-gel process typically yields silica-based particles that include covalent linkages to the reference and sensor dyes. In general, silica-based particles of the present invention can be prepared through the Stober sol-gel process by mixing a reactive reference dye with a co-reactive organosilane compound to form a reactive photoluminescent organosilane compound that can be co-condensed to form a core, followed by conjugation of a sensor dye to the core by mixing the core particle with the sensor dye and additional co-reactive organo/alkoxysilanes.
The sol-gel process may, however, be modified depending on the desired architecture of the particles. As previously mentioned, the silica-based particles of the present invention may exhibit various configurations, including an internal core comprising a silica-based matrix and a reference dye and an external shell comprising a sensor dye (Figs. IA and IB) and an internal core comprising a silica-based matrix, a
first shell comprising the reference dye and an outer shell surrounding the first shell and comprising the sensor dye (Fig. 1C and ID).
Preparation of the silica-based particles of Figs. IA comprises synthesis of the core, subsequent growth of a silica intermediate shell and formation of the sensor dye- rich silica shell. Synthesis of the core typically occurs in three steps. First, in an inert gas atmosphere, a silane compound is coupled to the reference dye at a mole ratio of silane to reference dye of about 50:1 in degassed ethanol to form a photoluminescent silane compound. This product - the reference dye conjugate - is then added under ambient conditions to an absolute ethanolic solution of ammonia and water, under vigorous stirring. A silica precursor, such as tetraethoxysilane, is then promptly added to yield a final reaction solution of reference dye conjugate, silica precursor, ammonia and water in concentrations of 1.7xlO"5 M, 0.05 M, 0.2 M and 0.855 M. This reaction proceeds for 12-18 hrs and produces dye-rich silicate cores, with diameters of about 5.0 nanometers. To this solution, additional silica precursor is slowly added to grow a silica shell, in an amount of about 5.55xlO"6 M per minute, to reach a final reaction condition of reference dye conjugate, silica precursor, ammonia and water of 1.7xlO"5 M, 1.055 M, 0.5 M and 0.855 M.
To prepare the core/shell particles for conjugation with the sensor dye, the particles are dialyzed once against ethanol for approximately 24 hours. The dialyzed solution is then diluted to avoid agglomeration of the particles during the sensor dye coupling reaction. The sensor dye is conjugated to the silane in a similar manner as above for the reference dye to form sensor dye conjugate, though in this case the molar ratio is much lower {i.e., 2:1 molar ratio of silane to sensor dye), to avoid excess animation of the particles during functionalization. This serves the dual purposes of avoiding agglomeration of particles and helping to prevent amines on the surface from
inhibiting the sensor dye's ability to sense. Thereafter, the sensor dye conjugate is mixed with a silica precursor in ethanol at a molar ratio of sensor dye conjugate to silica precursor of about 1.2xlO"5 M to 0.0125 M. This mixture is added drop-wise to the dialyzed solution of core/shell particles. After the solution is allowed to react, it is dialyzed against absolute ethanol, where it remains stable for at least several months without agglomeration. The final particles, shown in a scanning electron microscope at Fig. 2A are approximately 40.0 nanometers in diameter.
The size of the core as well as the size of the particles made with the sol-gel process can be altered. The synthesis that leads to the particle architecture shown in Fig IB follows. Silica and a reference dye conjugate, per above, are co-condensed in an ethalonic solution at concentrations of 2.13xlO"5 M reference dye conjugate, 0.2 M silica precursor, 0.625 M ammonia and 1.45 M water to yield monodisperse core particles of about 55.0 nanometers in diameter. To this mixture, sensor dye conjugate and additional silica precursor are added drop wise to yield a final reaction condition of 2.13xlO"5 M reference dye conjugate, 2.13xlO"5 M sensor dye conjugate, 0.254M silica precursor, 0.625 M ammonia and 1.45 M water. These particles, which lack an intermediate silica shell between the core and the sensor dye-containing outer shell, are then centrifuged and re-suspended twice in ethanol and twice in water to remove excess reagents. As shown in Fig. 2B, the final particles are approximately 60.0 to 80.0 nanometers in size and comprise a relatively large reference dye-rich core and a sensor dye-rich shell.
Preparation of the silica particle architecture shown in Fig. 1C entails slight modifications to foregoing processes. Silica precursor, ammonia and water at ratios of 0.17 M to 1.0M to 2.5M are combined in absolute ethanol under ambient conditions, with vigorous stirring. After the solution reacts, the reaction product is collected by
centrifiigation and re-suspended by ultrasonication with water and ethanol. The seed particles, comprised of silica, are then re-suspended in absolute ethanol with water and ammonia, followed by drop-wise addition of a pre-combined solution of silica precursor, reference conjugate and ethanol to yield a final reaction condition of reference conjugate, silica precursor, ammonia and water of 1.16M, 0.027M, 0.2M, and 2.0M, respectively. Following reaction for 12-18 hours, the particles are centrifuged and washed repeatedly with absolute ethanol and deionized water. A similar synthesis was preformed to create a sensor dye shell on these particles, using a sensor dye conjugate synthesized in ethanol under inert atmosphere and a 50.0 to 1.0 molar ratio of organosilane to sensor dye. The final particles, shown at Fig. 2C, are approximately 200.0 nanometers in size and comprise a silica-rich core surrounded by a first reference dye rich shell surrounded by a second sensor dye rich shell. In the fourth particle architecture, Fig. ID, an intermediate silica shell, between the reference and sensing dye layers is introduced by condensing pure silica precursors onto the first shell to ensure further protection of the encapsulated reference dye. To prepare the silica-based particles of the present invention using reverse micelles to incorporate dyes which lack appropriate conjugation chemistries, a microemulsion synthesis protocol is followed. Silica-based seed particles, with reference dye, are first synthesized using the Stδber sol-gel process. These seed particles are transferred from ethanol into an aqueous environment via dialysis or centrifugation and washing. The reactive concentrations required for sufficient surface coating are calculated based on the number of available surface silanol groups which is dependent upon particle size as well as concentration. The particles and any dextran- bound or otherwise hydrophilic dyes are added in aqueous solution into a reverse microemulsion formed in cyclohexane in the presence of a charged or uncharged
amphiphilic surfactant with or without co-surfactants, as needed. A concentrated solution of ammonia is added to catalyze condensation of a silica precursor, which is added last. One suitable surfactant/co-surfactant combination is Triton X-100® and n- hexanol.
A coating of about 2.0 to about 10.0 nanometers in thickness may be effectively attached to the particle surface in the presence of free dye molecules or dextran-bound dyes, which become trapped in the silica matrix as it forms, thus encapsulating the sensor dye molecules and creating a particle based sensor. In other words, rather than being covalently bonded to the silica-based matrix, the photoluminescent dyes are typically physically entrapped or entrained in the silica- based matrix. By adjusting the reaction pH and silica precursor concentrations, it is possible to tailor the porosity of the silica matrix to allow analytes to interface with entrapped dye molecules.
After the silica-based particles of the present invention have been synthesized, they may be used for sensing in both biological and non-biological systems. A number of sensing methodologies, including ratiometric sensing, spectral shift sensing and lifetime sensing are possible.
Environmental conditions as well as the presence and concentration of certain analytes, may be explored in biological and non-biological systems. The silica-based particles may be introduced into cells, cell membranes, tissues, prokaryotic systems {e.g., E. coli biofilms), solutions, reactions and bodies of water, like rivers and lakes. Several methods exist for introducing the silica-based particles into cells, including commercially available lipid vesicle based methods, microinjection, and antibody- specific uptake (during which a cell surface receptor mediates endocytosis of the particle). In phagocytic cells and some endocytic cells, uptake may occur
spontaneously. Based on the brightness levels exhibited by the particles, measurements may advantageously be taken through incorporation of only a single silica-based particle of the present invention into the target environment. Multiple silica-based particles may, however, be employed.
Through the introduction of multiple classes of analyte-specific sensors to an unknown environment, multiplexed measurements may be achieved. Multiplexing allows simultaneous interrogation of multiple photoluminescent species whose emission peaks may be deconvolved to yield the status of multiple analytes. This approach would be well suited to high-throughput analysis of the effects of stimuli (such as novel therapeutics) on cellular function. The silica-based particles may also be employed as sensors in various organisms, on animal cells or bodily fluids, including human cells or bodily fluids, such as blood or serum. Cells or fluids may be harvested and tested outside the body or a whole body imager may excite the dyes within the body and measure emission. In vitro sensing typically relies upon sensors comprising photoluminescent dyes in the visible spectrum. With in vivo testing, the sensors may be locally injected into a particular area or functionalized with antibodies that exhibit preferential interactions with certain cell surface receptors. Sensor dyes used for in vivo testing typically exhibit infrared or near infrared emission wavelengths.
The environmental conditions or analytes undergoing sensing may also vary. Environmental conditions, like pH levels and hydrophobic or hydrophilic states may be determined. The presence and concentration of ions, such as potassium, phosphate, sodium, calcium, copper, magnesium, chromium, chloride, fluoride and iron, heavy metals, such as cadmium, zinc, lead, selenium, mercury, nickel, as well as biomolecular substances, such as vitamins and amino acids, may also be evaluated.
Further, in vitro and in vivo testing with the silica-based particles of the present invention may advantageously be employed for ascertaining the redox status of cells within the body of a living organism. The redox status of a cell describes its oxidation- reduction potential (i.e., the potential of the cell to lose electrons (oxidation) versus its potential to gain electrons (reduction)). The energy on which cells rely is derived mainly from energy released through oxidation from organic molecules to oxygen, yielding an overall reducing environment within cells, which is carefully regulated. Externally or internally opposed challenges to the normal oxidative/reductive balance - redox stresses - have been shown to be indicative of negative cellular events, specifically tumorigenesis, and may be important in disease or injury states such as cancer and strokes.
The foregoing unknown conditions or analytes may be investigated through various sensing methodologies.
Ratiometric sensing, as used herein, means the determination of unknown environmental conditions based on ratios established for and corresponding to known environmental conditions. Major emission peak intensities of two or more photoluminescent dyes are measured under known environmental or analyte conditions. A calibration is perfoπned by calculating ratios of peak emission for the two dyes (sensor dye/reference dye); the ratios correspond to known conditions. The calibration forms a basis for determinations of unknown conditions through excitation and emission intensity measurement of particles comprising the same reference and sensor dyes under the unknown condition.
Spectral-shift based measurements operate under similar principles. Unknown environmental or analyte conditions are investigated through the use of calibration curves that are established based on the wavelengths of maximal emission exhibited by
reference and sensor dyes upon excitation under known conditions. Rather than relying upon ratios of peak emission intensities, however, the difference between maximum peak wavelengths (λmax) for the reference and sensor dyes is used as the dependent variable.
Lifetime-based sensing measures the excited state lifetimes of two or more photoluminescent dyes, one of which whose lifetime is known to be environmentally insensitive, and at least one of which whose lifetime is dependent upon a specific environmental condition or analyte. The fluorescence lifetime (τ) is the length of time that a photoluminescent dye spends in an excited state, from initial absorption of a photon until its emission; it is most often in the range from 10 ps to several nanoseconds. A calibration may be performed by measurement of the fluorescence lifetimes for multiple analyte concentrations, creating a basis for further concentration determinations.
To establish a baseline for the sensing, one or more particles are first introduced into an environment having known conditions. The particles are then excited by one or more selected wavelengths of a multi-photon light source, typically exhibiting an excitation wavelength between about 250.0 nm and about 800.0 nm, as appropriate for the absorption profiles of the reference and sensor dyes in the particle. Multiphoton excitation utilizes lasers (often Ti-Sapphire), which can be tuned to a variety of emission wavelengths. The long wavelength (700.0 nm to >1500.0 nm) photons are not readily absorbed by tissue or media but may induce multiphoton excitation in dye molecules at very high photon flux {i.e., at the focal point of the beam). While the reference dye typically exhibits a relatively constant wavelength and intensity of emission, the sensor dye exhibits emissions that correspond to environmental stimuli or to the presence or concentration of certain analytes.
Thus, after excitation of each of the reference and sensor dyes at specific levels, photon emissions may be measured. Measurement may be carried out using spectrofluorometry or fluorescence microscopy. Photoluminescent lifetime is measured using a pulsed laser source and a gated detector which measures the emission as a function of time following irradiation. Photoluminescent emission is collected in quartz or plastic cuvettes as a function of emission wavelength at 90 degrees to the excitation beam via photon counting on a photomultiplier tube or avalanche photodiode. With photoluminescent microscopy, images of individual cell- free samples comprising sensors subjected to different known conditions are collected. After photon emissions for the reference and sensor dyes are measured, emission ratios (γ = Isensor/Ireference), spectral shifts or photoluminescent lifetimes are plotted versus the known environmental condition to establish calibration curves. That is, the emissions taken in the presence of the known environmental condition or analyte are used to generate comparison data, which is correlated to the known condition. For example, calibration curves indicate the range of ratios that correspond to the known environmental conditions (e.g., in one embodiment, ratios between about 0.5 and about 0.8 could correspond to a pH between 6 and 7).
After the comparison data have been generated, they may be used to ascertain unknown environmental conditions or the presence and concentration of analytes. Particle emissions are recorded in the presence of the unknown condition or analyte, and the data are used to determine the unknown condition by comparing it with the comparison data established for the known conditions.
The silica-based particles of the present invention can be used in a variety of other applications, such as those disclosed in co-owned co-pending U.S. App. Serial
No. 10/306,614, entitled "Fluorescent Silica Based Nanoparticles." All uses disclosed therein are hereby incorporated by reference.
EXAMPLES
The following examples are intended to be illustrative, but in no way limiting of the present invention. These examples are not intended to limit the invention or its protection in any way.
Example 1 (pH sensing)
A 200.0 nanometer silica-based particle comprising a reference dye and a sensor dye based upon the architecture shown in Figure 1C was synthesized for use as a ratiometric sensor to detect environmental pH. Synthesis
In an inert gas atmosphere, 3-aminopropyl-triethoxy silane (APTS - Sigma Aldrich Chem. Corp.) was coupled to the isothiocyanate group of the reference dye tetramethylrhodamine (TRITC) at a mole ratio of APTS:TRITC = 50:1 in degassed ethanol (Pharmco 200 proof, degassed) to form a TRITC-conjugate. The TRITC conjugate was added under ambient atmosphere to an absolute ethanolic solution of ammonia (2.0M ethanol - Sigma Aldrich Chem. Corp.) and water to which is promptly added the silica precursor tetraethoxysilane (TEOS - 99% Sigma Aldrich Chem. Corp.) to yield a final reaction solution of [TRITC-conjugate], [TEOS], [NH3] and[H2O] of 1.7x1^ M, 0.17 M, 1.0 M and 2.5M. This reaction proceeded for 12-18 hrs and a hazy product was collected by centrifugation and resuspended by ultrasonication with water and ethanol.
The particles were resuspended at 0.787 mg/ml in absolute ethanol with appropriate water and NH3 concentrations and a pre-combined solution of TEOS, TRITC-conjugate and ethanol was added drop wise (7.5 x 10"7MτEθs/nώi) to yield a
final reaction condition of [TRITC-conjugate], [TEOS], [NH3] and [H2O] of 1.16mM, 0.2 7M, 0.2 M and 2.0 M. Following reaction for 12-18 hours, the particles were centrifuged and washed repeatedly with absolute ethanol and deionized water.
A similar synthesis was performed to create a fluorescein (FITC) shell on these particles, using a FITC conjugate synthesized under inert atmosphere at 4.25 mM FITC and a 50: 1 molar ratio of APTS to FITC. This conjugate was then added under similar conditions to the TRITC conjugate mixture prepared above with final concentrations of [FITC-conjugate], [TEOS], [NH3] and [H2O] of 0.4mM, 0.029mM, 0.2M and 2.0 M for a particle density of 0.787 mg/ml. The particles were approximately 200.0 nanometers in size (Fig 2C) and comprised a relatively large reference dye rich core and a sensor dye rich shell. Calibration
The particles were diluted from deionized water into sodium phosphate buffers between pH 5 and 9 at 3:20 (v/v) dilutions. The particles were then excited through introduction of a single photon light source at 540.0 nm to excite the tetramethylrhodamine and 490.0 nm to excite the fluorescein. The emission wavelengths were measured by spectrofluorometry (with a Photon Technologies International Spectrofluorometer); maximum peaks are shown in Fig. 3. The larger wavelength peaks correspond to the fluorescein sensor dye while the smaller peaks correspond to the tetramethylrhodamine reference dye. The ratio of peak maxima for emission wavelengths (γ = IFITC/ITRITC) was then plotted versus pH to give the calibration curves shown in Fig. 4. The calibration curves provide linear calibration over the range of pH from 5-9 for each set of tested particles.
Sensing
The silica-based particles synthesized above may be introduced into a solution of unknown pH. The particles may be excited with the same single photon light source used during calibration at the same excitation wavelengths. The ratio of peak maxima (γ = IFITC/ITRITC) for emission wavelengths may then be calculated and compared against the calibration curves of Fig. 4. In this way, the pH of the solution may be determined.
Variations, modifications and other implementations of what is described herein will occur to those of ordinary skill in the art without departing from the spirit and scope of the invention. Accordingly, the invention is in no way limited by the preceding illustrative description.
Claims
1. A silica-based particle comprising a silica-based core and two or more photoluminescent dyes, the two or more photoluminescent dyes comprising at least one reference dye and at least one sensor dye.
2. The silica-based particle of claim 1, wherein the silica-based particle is a nanoparticle.
3. The silica-based particles of claim 1, wherein the silica-based particle comprises pores including diameters between about 0.1 nm and about 100.0 nm.
4. The silica based particle of claim 1 , wherein at least one of the reference and sensor dyes is covalently bonded to the silica-based core.
5. The silica particle of claim 1 , wherein one of the reference and sensor dyes comprises between about 1.0 and about 1000.0 dye molecules and the reference and sensor dyes emit photons in response to a single excitation source emitting at a single predetermined wavelength.
6. The silica-based particle of claim 1, wherein the reference dye is positioned within the core and the sensor dye is positioned on at least a portion of a surface of the silica-based particle.
7. The silica-based particle of claim 1 , wherein the reference and sensor dyes are positioned on or over the core.
8. The silica-based particle of claim 1, further comprising a silica-based shell surrounding the core, wherein the reference dye is positioned within the core and the silica-based shell is interposed between the reference dye and the sensor dye.
9. The silica-based particle of claim 1, wherein the reference and sensor dyes emit photons in response to a single excitation source emitting at a single predetermined wavelength.
10. The silica-based particle of claim 1 , wherein peak wavelengths of the reference and sensor dyes in response to photon exposure are separated by a sufficient gap to individually discern the emission peaks.
11. The silica-based particle of claim 1 , wherein exposure of the reference or sensor dye to photon excitation results in infra-red or near infra-red emissions.
12. The silica particle of claim 1, wherein the sensor dye is responsive to at least one of pH, the presence and concentration of ions and chemical or biochemical analytes.
13. The silica-based particle of claim 1, further comprising a surface modifier that exhibits preferential interaction with a target analyte.
14. The silica particle of claim 1 , further comprising a therapeutic agent responsive to a disease state or injury.
15. A photoluminescent nanoparticle comprising two or more photoluminescent dyes and a plurality of pores, the two or more photoluminescent dyes comprising at least one reference dye and at least one sensor dye.
16. The photoluminescent nanoparticle of claim 15, wherein at least one of the pores includes a diameter between about 0.1 nanometers to about 100.0 nanometers.
17. The photoluminescent nanoparticle of claim 15, wherein a diameter of the nanoparticle is between about 1.0 and 250.0 nanometers.
18. A method comprising the steps of: providing at least one silica-based particle comprising two or more photoluminescent dyes; introducing the at least one silica-based particle into an environment comprising one or more unknown conditions or analytes; exposing the at least one silica-based particle to excitation photons, such that each of the two or more photoluminescent dyes emits photons; recording each of the photons emitted by the two or more photoluminescent dyes; determining the one or more unknown environmental conditions or analytes.
19. The method of claim 18, further comprising excitation of the two or more photoluminescent dyes with photons in the presence of a known environmental condition or analyte.
20. The method of claim 19, further comprising comparing the emissions of the two or more photoluminescent dyes taken in the presence of the known environmental condition or analyte to generate comparison data and correlating the comparison data to the known condition or analyte.
21. The method of claim 20, wherein the determining step includes using the comparison data to determine the unknown condition or analyte.
22. The method of claim 18, wherein the determining step comprises ratiometric sensing.
23. The method of claim 18, wherein the determining step comprises spectral shift sensing.
24. The method of claim 18 wherein the determining step comprises lifetime-based sensing.
25. The method of claim 18, wherein the determining step occurs in vitro or in vivo.
26. The method of claim 18, wherein the determining step is adapted to ascertain a redox state.
27. The method of claim 18, wherein the two or more photoluminescent dyes comprise a reference dye and a sensor dye and a single silica-based particle is used during the determining step.
28. The method of claim 18, wherein a whole body imager is utilized during the determining step.
29. The method of claim 18, further comprising introducing the at least one silica-based particle into a cell.
30. The method of claim 18, further comprising the step of treating a disease state with the at least one silica-based particle.
31. The method of claim 18, wherein the unknown condition or analyte is selected from the group consisting of ph, hydrophobic or hydrophilic environment, redox status, analyte identity and analyte concentration.
32. The method of claim 18, wherein the determining step comprises simultaneous interrogation of multiple sensor dyes whose emission peaks may be deconvolved to yield the status of multiple unknown conditions or analytes.
33. A method of determining an unknown condition in an organism, comprising the steps of: providing a silica-based nanoparticle comprising a sensor dye adapted to emit photons; inserting the silica-based nanoparticle into the organism; exciting the sensor dye with photons; detecting the emission of the sensor dye; and determining the unknown condition of the organism.
34. The method of claim 33, wherein the silica-based nanoparticle further comprises a reference dye.
35. The method of claim 33, wherein the silica-based nanoparticle further comprises a therapeutic agent for treating a disease state.
36. The method of claim 33 wherein the unknown condition is a redox state.
37. The method of claim 33, wherein the silica based nanoparticle is positioned within a cell or tissue of the organism.
38. The method of claim 33, wherein the silica-based nanoparticle is positioned within blood or other bodily fluids of the organism.
39. The method of claim 33, wherein the sensor dye emits at near infrared or infrared wavelengths.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06769923.1A EP1877772B1 (en) | 2005-05-02 | 2006-04-28 | Photoluminescent silica-based sensors and methods of use |
CN2006800217500A CN101198672B (en) | 2005-05-02 | 2006-04-28 | Photoluminescent silica-based sensors and methods of use |
JP2008510082A JP2008540308A (en) | 2005-05-02 | 2006-04-28 | Silica-based photoluminescence sensor and method of use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/119,969 US8084001B2 (en) | 2005-05-02 | 2005-05-02 | Photoluminescent silica-based sensors and methods of use |
US11/119,969 | 2005-05-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006119087A2 true WO2006119087A2 (en) | 2006-11-09 |
WO2006119087A3 WO2006119087A3 (en) | 2007-10-18 |
Family
ID=37234645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/016389 WO2006119087A2 (en) | 2005-05-02 | 2006-04-28 | Photoluminescent silica-based sensors and methods of use |
Country Status (5)
Country | Link |
---|---|
US (1) | US8084001B2 (en) |
EP (1) | EP1877772B1 (en) |
JP (1) | JP2008540308A (en) |
CN (1) | CN101198672B (en) |
WO (1) | WO2006119087A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012052068A1 (en) * | 2010-10-22 | 2012-04-26 | University College Cork, National University Of Ireland, Cork | Method and probe for monitoring oxygen status in live mammalian cells |
US8961825B2 (en) | 2009-04-15 | 2015-02-24 | Cornell University | Fluorescent silica nanoparticles through silica densification |
US11744897B2 (en) | 2020-10-27 | 2023-09-05 | Elucida Oncology, Inc. | Folate receptor targeted nanoparticle drug conjugates and uses thereof |
US11957760B2 (en) | 2023-03-14 | 2024-04-16 | Elucida Oncology, Inc. | Folate receptor targeted nanoparticle drug conjugates and uses thereof |
Families Citing this family (524)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9060770B2 (en) | 2003-05-20 | 2015-06-23 | Ethicon Endo-Surgery, Inc. | Robotically-driven surgical instrument with E-beam driver |
US20070084897A1 (en) | 2003-05-20 | 2007-04-19 | Shelton Frederick E Iv | Articulating surgical stapling instrument incorporating a two-piece e-beam firing mechanism |
US8215531B2 (en) | 2004-07-28 | 2012-07-10 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument having a medical substance dispenser |
US11890012B2 (en) | 2004-07-28 | 2024-02-06 | Cilag Gmbh International | Staple cartridge comprising cartridge body and attached support |
US9237891B2 (en) | 2005-08-31 | 2016-01-19 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical stapling devices that produce formed staples having different lengths |
US11484312B2 (en) | 2005-08-31 | 2022-11-01 | Cilag Gmbh International | Staple cartridge comprising a staple driver arrangement |
US8800838B2 (en) | 2005-08-31 | 2014-08-12 | Ethicon Endo-Surgery, Inc. | Robotically-controlled cable-based surgical end effectors |
US11246590B2 (en) | 2005-08-31 | 2022-02-15 | Cilag Gmbh International | Staple cartridge including staple drivers having different unfired heights |
US10159482B2 (en) | 2005-08-31 | 2018-12-25 | Ethicon Llc | Fastener cartridge assembly comprising a fixed anvil and different staple heights |
US20070194079A1 (en) | 2005-08-31 | 2007-08-23 | Hueil Joseph C | Surgical stapling device with staple drivers of different height |
US7934630B2 (en) | 2005-08-31 | 2011-05-03 | Ethicon Endo-Surgery, Inc. | Staple cartridges for forming staples having differing formed staple heights |
US7669746B2 (en) | 2005-08-31 | 2010-03-02 | Ethicon Endo-Surgery, Inc. | Staple cartridges for forming staples having differing formed staple heights |
US20070106317A1 (en) | 2005-11-09 | 2007-05-10 | Shelton Frederick E Iv | Hydraulically and electrically actuated articulation joints for surgical instruments |
US9861359B2 (en) | 2006-01-31 | 2018-01-09 | Ethicon Llc | Powered surgical instruments with firing system lockout arrangements |
US11793518B2 (en) | 2006-01-31 | 2023-10-24 | Cilag Gmbh International | Powered surgical instruments with firing system lockout arrangements |
US8708213B2 (en) | 2006-01-31 | 2014-04-29 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a feedback system |
US8186555B2 (en) | 2006-01-31 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting and fastening instrument with mechanical closure system |
US20110024477A1 (en) | 2009-02-06 | 2011-02-03 | Hall Steven G | Driven Surgical Stapler Improvements |
US7753904B2 (en) | 2006-01-31 | 2010-07-13 | Ethicon Endo-Surgery, Inc. | Endoscopic surgical instrument with a handle that can articulate with respect to the shaft |
US8820603B2 (en) | 2006-01-31 | 2014-09-02 | Ethicon Endo-Surgery, Inc. | Accessing data stored in a memory of a surgical instrument |
US11278279B2 (en) | 2006-01-31 | 2022-03-22 | Cilag Gmbh International | Surgical instrument assembly |
US20110006101A1 (en) | 2009-02-06 | 2011-01-13 | EthiconEndo-Surgery, Inc. | Motor driven surgical fastener device with cutting member lockout arrangements |
US8161977B2 (en) | 2006-01-31 | 2012-04-24 | Ethicon Endo-Surgery, Inc. | Accessing data stored in a memory of a surgical instrument |
US11224427B2 (en) | 2006-01-31 | 2022-01-18 | Cilag Gmbh International | Surgical stapling system including a console and retraction assembly |
US20120292367A1 (en) | 2006-01-31 | 2012-11-22 | Ethicon Endo-Surgery, Inc. | Robotically-controlled end effector |
US7845537B2 (en) | 2006-01-31 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Surgical instrument having recording capabilities |
US20110290856A1 (en) | 2006-01-31 | 2011-12-01 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical instrument with force-feedback capabilities |
US8763879B2 (en) | 2006-01-31 | 2014-07-01 | Ethicon Endo-Surgery, Inc. | Accessing data stored in a memory of surgical instrument |
US8992422B2 (en) | 2006-03-23 | 2015-03-31 | Ethicon Endo-Surgery, Inc. | Robotically-controlled endoscopic accessory channel |
US20070225562A1 (en) | 2006-03-23 | 2007-09-27 | Ethicon Endo-Surgery, Inc. | Articulating endoscopic accessory channel |
EP2530168B1 (en) | 2006-05-11 | 2015-09-16 | Raindance Technologies, Inc. | Microfluidic Devices |
US8322455B2 (en) | 2006-06-27 | 2012-12-04 | Ethicon Endo-Surgery, Inc. | Manually driven surgical cutting and fastening instrument |
US20080086051A1 (en) * | 2006-09-20 | 2008-04-10 | Ethicon Endo-Surgery, Inc. | System, storage medium for a computer program, and method for displaying medical images |
US9079762B2 (en) | 2006-09-22 | 2015-07-14 | Ethicon Endo-Surgery, Inc. | Micro-electromechanical device |
US7506791B2 (en) | 2006-09-29 | 2009-03-24 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument with mechanical mechanism for limiting maximum tissue compression |
US10568652B2 (en) | 2006-09-29 | 2020-02-25 | Ethicon Llc | Surgical staples having attached drivers of different heights and stapling instruments for deploying the same |
US10130359B2 (en) | 2006-09-29 | 2018-11-20 | Ethicon Llc | Method for forming a staple |
US7713265B2 (en) | 2006-12-22 | 2010-05-11 | Ethicon Endo-Surgery, Inc. | Apparatus and method for medically treating a tattoo |
US8273015B2 (en) | 2007-01-09 | 2012-09-25 | Ethicon Endo-Surgery, Inc. | Methods for imaging the anatomy with an anatomically secured scanner assembly |
US8801606B2 (en) | 2007-01-09 | 2014-08-12 | Ethicon Endo-Surgery, Inc. | Method of in vivo monitoring using an imaging system including scanned beam imaging unit |
US8684253B2 (en) | 2007-01-10 | 2014-04-01 | Ethicon Endo-Surgery, Inc. | Surgical instrument with wireless communication between a control unit of a robotic system and remote sensor |
US8652120B2 (en) | 2007-01-10 | 2014-02-18 | Ethicon Endo-Surgery, Inc. | Surgical instrument with wireless communication between control unit and sensor transponders |
US8459520B2 (en) | 2007-01-10 | 2013-06-11 | Ethicon Endo-Surgery, Inc. | Surgical instrument with wireless communication between control unit and remote sensor |
US11291441B2 (en) | 2007-01-10 | 2022-04-05 | Cilag Gmbh International | Surgical instrument with wireless communication between control unit and remote sensor |
US8540128B2 (en) | 2007-01-11 | 2013-09-24 | Ethicon Endo-Surgery, Inc. | Surgical stapling device with a curved end effector |
US11039836B2 (en) | 2007-01-11 | 2021-06-22 | Cilag Gmbh International | Staple cartridge for use with a surgical stapling instrument |
WO2008097559A2 (en) | 2007-02-06 | 2008-08-14 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
US8155728B2 (en) * | 2007-08-22 | 2012-04-10 | Ethicon Endo-Surgery, Inc. | Medical system, method, and storage medium concerning a natural orifice transluminal medical procedure |
US8457718B2 (en) * | 2007-03-21 | 2013-06-04 | Ethicon Endo-Surgery, Inc. | Recognizing a real world fiducial in a patient image data |
US20080221434A1 (en) * | 2007-03-09 | 2008-09-11 | Voegele James W | Displaying an internal image of a body lumen of a patient |
US8216214B2 (en) | 2007-03-12 | 2012-07-10 | Ethicon Endo-Surgery, Inc. | Power modulation of a scanning beam for imaging, therapy, and/or diagnosis |
US8727197B2 (en) | 2007-03-15 | 2014-05-20 | Ethicon Endo-Surgery, Inc. | Staple cartridge cavity configuration with cooperative surgical staple |
US20080234544A1 (en) * | 2007-03-20 | 2008-09-25 | Ethicon Endo-Sugery, Inc. | Displaying images interior and exterior to a body lumen of a patient |
US8081810B2 (en) * | 2007-03-22 | 2011-12-20 | Ethicon Endo-Surgery, Inc. | Recognizing a real world fiducial in image data of a patient |
US8893946B2 (en) | 2007-03-28 | 2014-11-25 | Ethicon Endo-Surgery, Inc. | Laparoscopic tissue thickness and clamp load measuring devices |
US8626271B2 (en) | 2007-04-13 | 2014-01-07 | Ethicon Endo-Surgery, Inc. | System and method using fluorescence to examine within a patient's anatomy |
US7995045B2 (en) | 2007-04-13 | 2011-08-09 | Ethicon Endo-Surgery, Inc. | Combined SBI and conventional image processor |
US20080255460A1 (en) * | 2007-04-13 | 2008-10-16 | Ethicon Endo-Surgery, Inc. | Nanoparticle tissue based identification and illumination |
WO2008130623A1 (en) | 2007-04-19 | 2008-10-30 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
US7832408B2 (en) | 2007-06-04 | 2010-11-16 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a directional switching mechanism |
US11857181B2 (en) | 2007-06-04 | 2024-01-02 | Cilag Gmbh International | Robotically-controlled shaft based rotary drive systems for surgical instruments |
US7905380B2 (en) | 2007-06-04 | 2011-03-15 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a multiple rate directional switching mechanism |
US8931682B2 (en) | 2007-06-04 | 2015-01-13 | Ethicon Endo-Surgery, Inc. | Robotically-controlled shaft based rotary drive systems for surgical instruments |
US8534528B2 (en) | 2007-06-04 | 2013-09-17 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a multiple rate directional switching mechanism |
US8160678B2 (en) | 2007-06-18 | 2012-04-17 | Ethicon Endo-Surgery, Inc. | Methods and devices for repairing damaged or diseased tissue using a scanning beam assembly |
US7753245B2 (en) | 2007-06-22 | 2010-07-13 | Ethicon Endo-Surgery, Inc. | Surgical stapling instruments |
US8308040B2 (en) | 2007-06-22 | 2012-11-13 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument with an articulatable end effector |
US11849941B2 (en) | 2007-06-29 | 2023-12-26 | Cilag Gmbh International | Staple cartridge having staple cavities extending at a transverse angle relative to a longitudinal cartridge axis |
US7982776B2 (en) | 2007-07-13 | 2011-07-19 | Ethicon Endo-Surgery, Inc. | SBI motion artifact removal apparatus and method |
US9125552B2 (en) | 2007-07-31 | 2015-09-08 | Ethicon Endo-Surgery, Inc. | Optical scanning module and means for attaching the module to medical instruments for introducing the module into the anatomy |
US7983739B2 (en) | 2007-08-27 | 2011-07-19 | Ethicon Endo-Surgery, Inc. | Position tracking and control for a scanning assembly |
US7925333B2 (en) | 2007-08-28 | 2011-04-12 | Ethicon Endo-Surgery, Inc. | Medical device including scanned beam unit with operational control features |
US8561870B2 (en) | 2008-02-13 | 2013-10-22 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument |
BRPI0901282A2 (en) | 2008-02-14 | 2009-11-17 | Ethicon Endo Surgery Inc | surgical cutting and fixation instrument with rf electrodes |
US8584919B2 (en) | 2008-02-14 | 2013-11-19 | Ethicon Endo-Sugery, Inc. | Surgical stapling apparatus with load-sensitive firing mechanism |
US8459525B2 (en) | 2008-02-14 | 2013-06-11 | Ethicon Endo-Sugery, Inc. | Motorized surgical cutting and fastening instrument having a magnetic drive train torque limiting device |
US7819298B2 (en) | 2008-02-14 | 2010-10-26 | Ethicon Endo-Surgery, Inc. | Surgical stapling apparatus with control features operable with one hand |
US8622274B2 (en) | 2008-02-14 | 2014-01-07 | Ethicon Endo-Surgery, Inc. | Motorized cutting and fastening instrument having control circuit for optimizing battery usage |
US9179912B2 (en) | 2008-02-14 | 2015-11-10 | Ethicon Endo-Surgery, Inc. | Robotically-controlled motorized surgical cutting and fastening instrument |
US8758391B2 (en) | 2008-02-14 | 2014-06-24 | Ethicon Endo-Surgery, Inc. | Interchangeable tools for surgical instruments |
US7793812B2 (en) | 2008-02-14 | 2010-09-14 | Ethicon Endo-Surgery, Inc. | Disposable motor-driven loading unit for use with a surgical cutting and stapling apparatus |
US8657174B2 (en) | 2008-02-14 | 2014-02-25 | Ethicon Endo-Surgery, Inc. | Motorized surgical cutting and fastening instrument having handle based power source |
US8752749B2 (en) | 2008-02-14 | 2014-06-17 | Ethicon Endo-Surgery, Inc. | Robotically-controlled disposable motor-driven loading unit |
US8573465B2 (en) | 2008-02-14 | 2013-11-05 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical end effector system with rotary actuated closure systems |
US7866527B2 (en) | 2008-02-14 | 2011-01-11 | Ethicon Endo-Surgery, Inc. | Surgical stapling apparatus with interlockable firing system |
US8636736B2 (en) | 2008-02-14 | 2014-01-28 | Ethicon Endo-Surgery, Inc. | Motorized surgical cutting and fastening instrument |
US9770245B2 (en) | 2008-02-15 | 2017-09-26 | Ethicon Llc | Layer arrangements for surgical staple cartridges |
US11272927B2 (en) | 2008-02-15 | 2022-03-15 | Cilag Gmbh International | Layer arrangements for surgical staple cartridges |
US20090217932A1 (en) * | 2008-03-03 | 2009-09-03 | Ethicon Endo-Surgery, Inc. | Intraluminal tissue markers |
US8050520B2 (en) | 2008-03-27 | 2011-11-01 | Ethicon Endo-Surgery, Inc. | Method for creating a pixel image from sampled data of a scanned beam imager |
US8332014B2 (en) | 2008-04-25 | 2012-12-11 | Ethicon Endo-Surgery, Inc. | Scanned beam device and method using same which measures the reflectance of patient tissue |
EP4047367A1 (en) | 2008-07-18 | 2022-08-24 | Bio-Rad Laboratories, Inc. | Method for detecting target analytes with droplet libraries |
PL3476312T3 (en) | 2008-09-19 | 2024-03-11 | Ethicon Llc | Surgical stapler with apparatus for adjusting staple height |
US7857186B2 (en) | 2008-09-19 | 2010-12-28 | Ethicon Endo-Surgery, Inc. | Surgical stapler having an intermediate closing position |
US9386983B2 (en) | 2008-09-23 | 2016-07-12 | Ethicon Endo-Surgery, Llc | Robotically-controlled motorized surgical instrument |
US8210411B2 (en) | 2008-09-23 | 2012-07-03 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting instrument |
US9050083B2 (en) | 2008-09-23 | 2015-06-09 | Ethicon Endo-Surgery, Inc. | Motorized surgical instrument |
US9005230B2 (en) | 2008-09-23 | 2015-04-14 | Ethicon Endo-Surgery, Inc. | Motorized surgical instrument |
US11648005B2 (en) | 2008-09-23 | 2023-05-16 | Cilag Gmbh International | Robotically-controlled motorized surgical instrument with an end effector |
US8608045B2 (en) | 2008-10-10 | 2013-12-17 | Ethicon Endo-Sugery, Inc. | Powered surgical cutting and stapling apparatus with manually retractable firing system |
US8397971B2 (en) | 2009-02-05 | 2013-03-19 | Ethicon Endo-Surgery, Inc. | Sterilizable surgical instrument |
US8414577B2 (en) | 2009-02-05 | 2013-04-09 | Ethicon Endo-Surgery, Inc. | Surgical instruments and components for use in sterile environments |
US8517239B2 (en) | 2009-02-05 | 2013-08-27 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument comprising a magnetic element driver |
US8444036B2 (en) | 2009-02-06 | 2013-05-21 | Ethicon Endo-Surgery, Inc. | Motor driven surgical fastener device with mechanisms for adjusting a tissue gap within the end effector |
CN102341048A (en) | 2009-02-06 | 2012-02-01 | 伊西康内外科公司 | Driven surgical stapler improvements |
US20100330366A1 (en) * | 2009-06-30 | 2010-12-30 | Keiser Bruce A | Silica-based particle composition |
US9999694B2 (en) | 2009-07-02 | 2018-06-19 | Sloan-Kettering Institute For Cancer Research | Multimodal silica-based nanoparticles |
WO2011042564A1 (en) * | 2009-10-09 | 2011-04-14 | Universite De Strasbourg | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
US8220688B2 (en) | 2009-12-24 | 2012-07-17 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting instrument with electric actuator directional control assembly |
US8851354B2 (en) | 2009-12-24 | 2014-10-07 | Ethicon Endo-Surgery, Inc. | Surgical cutting instrument that analyzes tissue thickness |
US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
EP2534267B1 (en) | 2010-02-12 | 2018-04-11 | Raindance Technologies, Inc. | Digital analyte analysis |
US20110278536A1 (en) * | 2010-05-17 | 2011-11-17 | Massachusetts Institute Of Technology | Light emitting material |
US8783543B2 (en) | 2010-07-30 | 2014-07-22 | Ethicon Endo-Surgery, Inc. | Tissue acquisition arrangements and methods for surgical stapling devices |
US9877720B2 (en) | 2010-09-24 | 2018-01-30 | Ethicon Llc | Control features for articulating surgical device |
US9204880B2 (en) | 2012-03-28 | 2015-12-08 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensator comprising capsules defining a low pressure environment |
US9414838B2 (en) | 2012-03-28 | 2016-08-16 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator comprised of a plurality of materials |
US9282962B2 (en) | 2010-09-30 | 2016-03-15 | Ethicon Endo-Surgery, Llc | Adhesive film laminate |
US9055941B2 (en) | 2011-09-23 | 2015-06-16 | Ethicon Endo-Surgery, Inc. | Staple cartridge including collapsible deck |
US9517063B2 (en) | 2012-03-28 | 2016-12-13 | Ethicon Endo-Surgery, Llc | Movable member for use with a tissue thickness compensator |
US9386988B2 (en) | 2010-09-30 | 2016-07-12 | Ethicon End-Surgery, LLC | Retainer assembly including a tissue thickness compensator |
US9433419B2 (en) | 2010-09-30 | 2016-09-06 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensator comprising a plurality of layers |
US11849952B2 (en) | 2010-09-30 | 2023-12-26 | Cilag Gmbh International | Staple cartridge comprising staples positioned within a compressible portion thereof |
EP2621356B1 (en) | 2010-09-30 | 2018-03-07 | Ethicon LLC | Fastener system comprising a retention matrix and an alignment matrix |
US9629814B2 (en) | 2010-09-30 | 2017-04-25 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator configured to redistribute compressive forces |
US9364233B2 (en) | 2010-09-30 | 2016-06-14 | Ethicon Endo-Surgery, Llc | Tissue thickness compensators for circular surgical staplers |
US11812965B2 (en) | 2010-09-30 | 2023-11-14 | Cilag Gmbh International | Layer of material for a surgical end effector |
US9314246B2 (en) | 2010-09-30 | 2016-04-19 | Ethicon Endo-Surgery, Llc | Tissue stapler having a thickness compensator incorporating an anti-inflammatory agent |
US9307989B2 (en) | 2012-03-28 | 2016-04-12 | Ethicon Endo-Surgery, Llc | Tissue stapler having a thickness compensator incorportating a hydrophobic agent |
US9220501B2 (en) | 2010-09-30 | 2015-12-29 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensators |
US9211120B2 (en) | 2011-04-29 | 2015-12-15 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensator comprising a plurality of medicaments |
US9332974B2 (en) | 2010-09-30 | 2016-05-10 | Ethicon Endo-Surgery, Llc | Layered tissue thickness compensator |
US8893949B2 (en) | 2010-09-30 | 2014-11-25 | Ethicon Endo-Surgery, Inc. | Surgical stapler with floating anvil |
US9016542B2 (en) | 2010-09-30 | 2015-04-28 | Ethicon Endo-Surgery, Inc. | Staple cartridge comprising compressible distortion resistant components |
US10945731B2 (en) | 2010-09-30 | 2021-03-16 | Ethicon Llc | Tissue thickness compensator comprising controlled release and expansion |
US11298125B2 (en) | 2010-09-30 | 2022-04-12 | Cilag Gmbh International | Tissue stapler having a thickness compensator |
US8491488B1 (en) | 2010-10-01 | 2013-07-23 | Blaufuss Medical Multimedia Laboratories, LLC | Method and system for identifying cardiopulmonary findings by using a heart and lung sounds builder |
US8695866B2 (en) | 2010-10-01 | 2014-04-15 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a power control circuit |
US9525092B2 (en) * | 2010-11-05 | 2016-12-20 | Pacific Light Technologies Corp. | Solar module employing quantum luminescent lateral transfer concentrator |
US9011735B2 (en) | 2010-12-30 | 2015-04-21 | Ut-Battelle, Llc | Volume-labeled nanoparticles and methods of preparation |
US9150852B2 (en) | 2011-02-18 | 2015-10-06 | Raindance Technologies, Inc. | Compositions and methods for molecular labeling |
CA2834649C (en) | 2011-04-29 | 2021-02-16 | Ethicon Endo-Surgery, Inc. | Staple cartridge comprising staples positioned within a compressible portion thereof |
US11207064B2 (en) | 2011-05-27 | 2021-12-28 | Cilag Gmbh International | Automated end effector component reloading system for use with a robotic system |
US9072535B2 (en) | 2011-05-27 | 2015-07-07 | Ethicon Endo-Surgery, Inc. | Surgical stapling instruments with rotatable staple deployment arrangements |
EP3709018A1 (en) | 2011-06-02 | 2020-09-16 | Bio-Rad Laboratories, Inc. | Microfluidic apparatus for identifying components of a chemical reaction |
US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
US8691500B2 (en) * | 2011-07-29 | 2014-04-08 | Korea Institute Of Science And Technology | Device and method for detecting biomolecule |
US9050084B2 (en) | 2011-09-23 | 2015-06-09 | Ethicon Endo-Surgery, Inc. | Staple cartridge including collapsible deck arrangement |
US20130112942A1 (en) | 2011-11-09 | 2013-05-09 | Juanita Kurtin | Composite having semiconductor structures embedded in a matrix |
US9044230B2 (en) | 2012-02-13 | 2015-06-02 | Ethicon Endo-Surgery, Inc. | Surgical cutting and fastening instrument with apparatus for determining cartridge and firing motion status |
BR112014024098B1 (en) | 2012-03-28 | 2021-05-25 | Ethicon Endo-Surgery, Inc. | staple cartridge |
CN104379068B (en) | 2012-03-28 | 2017-09-22 | 伊西康内外科公司 | Holding device assembly including tissue thickness compensation part |
US9198662B2 (en) | 2012-03-28 | 2015-12-01 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensator having improved visibility |
BR112014024102B1 (en) | 2012-03-28 | 2022-03-03 | Ethicon Endo-Surgery, Inc | CLAMP CARTRIDGE ASSEMBLY FOR A SURGICAL INSTRUMENT AND END ACTUATOR ASSEMBLY FOR A SURGICAL INSTRUMENT |
US9101358B2 (en) | 2012-06-15 | 2015-08-11 | Ethicon Endo-Surgery, Inc. | Articulatable surgical instrument comprising a firing drive |
US9101385B2 (en) | 2012-06-28 | 2015-08-11 | Ethicon Endo-Surgery, Inc. | Electrode connections for rotary driven surgical tools |
US9125662B2 (en) | 2012-06-28 | 2015-09-08 | Ethicon Endo-Surgery, Inc. | Multi-axis articulating and rotating surgical tools |
US11278284B2 (en) | 2012-06-28 | 2022-03-22 | Cilag Gmbh International | Rotary drive arrangements for surgical instruments |
US8747238B2 (en) | 2012-06-28 | 2014-06-10 | Ethicon Endo-Surgery, Inc. | Rotary drive shaft assemblies for surgical instruments with articulatable end effectors |
US9226751B2 (en) | 2012-06-28 | 2016-01-05 | Ethicon Endo-Surgery, Inc. | Surgical instrument system including replaceable end effectors |
US9204879B2 (en) | 2012-06-28 | 2015-12-08 | Ethicon Endo-Surgery, Inc. | Flexible drive member |
BR112014032776B1 (en) | 2012-06-28 | 2021-09-08 | Ethicon Endo-Surgery, Inc | SURGICAL INSTRUMENT SYSTEM AND SURGICAL KIT FOR USE WITH A SURGICAL INSTRUMENT SYSTEM |
US20140001231A1 (en) | 2012-06-28 | 2014-01-02 | Ethicon Endo-Surgery, Inc. | Firing system lockout arrangements for surgical instruments |
US9282974B2 (en) | 2012-06-28 | 2016-03-15 | Ethicon Endo-Surgery, Llc | Empty clip cartridge lockout |
US9072536B2 (en) | 2012-06-28 | 2015-07-07 | Ethicon Endo-Surgery, Inc. | Differential locking arrangements for rotary powered surgical instruments |
US9289256B2 (en) | 2012-06-28 | 2016-03-22 | Ethicon Endo-Surgery, Llc | Surgical end effectors having angled tissue-contacting surfaces |
US9561038B2 (en) | 2012-06-28 | 2017-02-07 | Ethicon Endo-Surgery, Llc | Interchangeable clip applier |
US9119657B2 (en) | 2012-06-28 | 2015-09-01 | Ethicon Endo-Surgery, Inc. | Rotary actuatable closure arrangement for surgical end effector |
US9028494B2 (en) | 2012-06-28 | 2015-05-12 | Ethicon Endo-Surgery, Inc. | Interchangeable end effector coupling arrangement |
JP6290201B2 (en) | 2012-06-28 | 2018-03-07 | エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. | Lockout for empty clip cartridge |
WO2014086411A1 (en) | 2012-12-05 | 2014-06-12 | Luxcel Biosciences Limited | Individually and flexibly deployable target-analyte sensitive particulate probes and method of making and using |
US9386984B2 (en) | 2013-02-08 | 2016-07-12 | Ethicon Endo-Surgery, Llc | Staple cartridge comprising a releasable cover |
US10092292B2 (en) | 2013-02-28 | 2018-10-09 | Ethicon Llc | Staple forming features for surgical stapling instrument |
JP6345707B2 (en) | 2013-03-01 | 2018-06-20 | エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. | Surgical instrument with soft stop |
US20140246475A1 (en) | 2013-03-01 | 2014-09-04 | Ethicon Endo-Surgery, Inc. | Control methods for surgical instruments with removable implement portions |
JP6382235B2 (en) | 2013-03-01 | 2018-08-29 | エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. | Articulatable surgical instrument with a conductive path for signal communication |
US20140263552A1 (en) | 2013-03-13 | 2014-09-18 | Ethicon Endo-Surgery, Inc. | Staple cartridge tissue thickness sensor system |
US9629629B2 (en) | 2013-03-14 | 2017-04-25 | Ethicon Endo-Surgey, LLC | Control systems for surgical instruments |
US9332987B2 (en) | 2013-03-14 | 2016-05-10 | Ethicon Endo-Surgery, Llc | Control arrangements for a drive member of a surgical instrument |
US9332984B2 (en) | 2013-03-27 | 2016-05-10 | Ethicon Endo-Surgery, Llc | Fastener cartridge assemblies |
US9572577B2 (en) | 2013-03-27 | 2017-02-21 | Ethicon Endo-Surgery, Llc | Fastener cartridge comprising a tissue thickness compensator including openings therein |
US9795384B2 (en) | 2013-03-27 | 2017-10-24 | Ethicon Llc | Fastener cartridge comprising a tissue thickness compensator and a gap setting element |
BR112015026109B1 (en) | 2013-04-16 | 2022-02-22 | Ethicon Endo-Surgery, Inc | surgical instrument |
US9844368B2 (en) | 2013-04-16 | 2017-12-19 | Ethicon Llc | Surgical system comprising first and second drive systems |
US9574644B2 (en) | 2013-05-30 | 2017-02-21 | Ethicon Endo-Surgery, Llc | Power module for use with a surgical instrument |
JP6416260B2 (en) | 2013-08-23 | 2018-10-31 | エシコン エルエルシー | Firing member retractor for a powered surgical instrument |
US20150053746A1 (en) | 2013-08-23 | 2015-02-26 | Ethicon Endo-Surgery, Inc. | Torque optimization for surgical instruments |
US9944977B2 (en) | 2013-12-12 | 2018-04-17 | Raindance Technologies, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
US20150173756A1 (en) | 2013-12-23 | 2015-06-25 | Ethicon Endo-Surgery, Inc. | Surgical cutting and stapling methods |
US9724092B2 (en) | 2013-12-23 | 2017-08-08 | Ethicon Llc | Modular surgical instruments |
US9968354B2 (en) | 2013-12-23 | 2018-05-15 | Ethicon Llc | Surgical staples and methods for making the same |
US9839428B2 (en) | 2013-12-23 | 2017-12-12 | Ethicon Llc | Surgical cutting and stapling instruments with independent jaw control features |
RU2016127260A (en) | 2013-12-31 | 2018-02-06 | Мемориал Слоун Кеттеринг Кэнсэ Сентр | SYSTEMS, METHODS AND DEVICE FOR MULTI-CHANNEL DISPLAY OF FLUORESCENT SOURCES IN REAL TIME |
US9962161B2 (en) | 2014-02-12 | 2018-05-08 | Ethicon Llc | Deliverable surgical instrument |
US9839422B2 (en) | 2014-02-24 | 2017-12-12 | Ethicon Llc | Implantable layers and methods for altering implantable layers for use with surgical fastening instruments |
CN106232029B (en) | 2014-02-24 | 2019-04-12 | 伊西康内外科有限责任公司 | Fastening system including firing member locking piece |
US10201364B2 (en) | 2014-03-26 | 2019-02-12 | Ethicon Llc | Surgical instrument comprising a rotatable shaft |
US9733663B2 (en) | 2014-03-26 | 2017-08-15 | Ethicon Llc | Power management through segmented circuit and variable voltage protection |
BR112016021943B1 (en) | 2014-03-26 | 2022-06-14 | Ethicon Endo-Surgery, Llc | SURGICAL INSTRUMENT FOR USE BY AN OPERATOR IN A SURGICAL PROCEDURE |
US10004497B2 (en) | 2014-03-26 | 2018-06-26 | Ethicon Llc | Interface systems for use with surgical instruments |
US9913642B2 (en) | 2014-03-26 | 2018-03-13 | Ethicon Llc | Surgical instrument comprising a sensor system |
JP6636452B2 (en) | 2014-04-16 | 2020-01-29 | エシコン エルエルシーEthicon LLC | Fastener cartridge including extension having different configurations |
BR112016023825B1 (en) | 2014-04-16 | 2022-08-02 | Ethicon Endo-Surgery, Llc | STAPLE CARTRIDGE FOR USE WITH A SURGICAL STAPLER AND STAPLE CARTRIDGE FOR USE WITH A SURGICAL INSTRUMENT |
JP6532889B2 (en) | 2014-04-16 | 2019-06-19 | エシコン エルエルシーEthicon LLC | Fastener cartridge assembly and staple holder cover arrangement |
US20150297223A1 (en) | 2014-04-16 | 2015-10-22 | Ethicon Endo-Surgery, Inc. | Fastener cartridges including extensions having different configurations |
US10561422B2 (en) | 2014-04-16 | 2020-02-18 | Ethicon Llc | Fastener cartridge comprising deployable tissue engaging members |
US10327764B2 (en) | 2014-09-26 | 2019-06-25 | Ethicon Llc | Method for creating a flexible staple line |
CA3201974A1 (en) | 2014-05-29 | 2015-12-03 | Memorial Sloan Kettering Cancer Center | Nanoparticle drug conjugates |
US10045781B2 (en) | 2014-06-13 | 2018-08-14 | Ethicon Llc | Closure lockout systems for surgical instruments |
US10111679B2 (en) | 2014-09-05 | 2018-10-30 | Ethicon Llc | Circuitry and sensors for powered medical device |
US11311294B2 (en) | 2014-09-05 | 2022-04-26 | Cilag Gmbh International | Powered medical device including measurement of closure state of jaws |
BR112017004361B1 (en) | 2014-09-05 | 2023-04-11 | Ethicon Llc | ELECTRONIC SYSTEM FOR A SURGICAL INSTRUMENT |
US10105142B2 (en) | 2014-09-18 | 2018-10-23 | Ethicon Llc | Surgical stapler with plurality of cutting elements |
US11523821B2 (en) | 2014-09-26 | 2022-12-13 | Cilag Gmbh International | Method for creating a flexible staple line |
JP6648119B2 (en) | 2014-09-26 | 2020-02-14 | エシコン エルエルシーEthicon LLC | Surgical stapling buttress and accessory materials |
US10076325B2 (en) | 2014-10-13 | 2018-09-18 | Ethicon Llc | Surgical stapling apparatus comprising a tissue stop |
US9924944B2 (en) | 2014-10-16 | 2018-03-27 | Ethicon Llc | Staple cartridge comprising an adjunct material |
US11141153B2 (en) | 2014-10-29 | 2021-10-12 | Cilag Gmbh International | Staple cartridges comprising driver arrangements |
US10517594B2 (en) | 2014-10-29 | 2019-12-31 | Ethicon Llc | Cartridge assemblies for surgical staplers |
US9844376B2 (en) | 2014-11-06 | 2017-12-19 | Ethicon Llc | Staple cartridge comprising a releasable adjunct material |
US10736636B2 (en) | 2014-12-10 | 2020-08-11 | Ethicon Llc | Articulatable surgical instrument system |
US10117649B2 (en) | 2014-12-18 | 2018-11-06 | Ethicon Llc | Surgical instrument assembly comprising a lockable articulation system |
US9844375B2 (en) | 2014-12-18 | 2017-12-19 | Ethicon Llc | Drive arrangements for articulatable surgical instruments |
US10188385B2 (en) | 2014-12-18 | 2019-01-29 | Ethicon Llc | Surgical instrument system comprising lockable systems |
US10004501B2 (en) | 2014-12-18 | 2018-06-26 | Ethicon Llc | Surgical instruments with improved closure arrangements |
US9844374B2 (en) | 2014-12-18 | 2017-12-19 | Ethicon Llc | Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member |
US10085748B2 (en) | 2014-12-18 | 2018-10-02 | Ethicon Llc | Locking arrangements for detachable shaft assemblies with articulatable surgical end effectors |
US9987000B2 (en) | 2014-12-18 | 2018-06-05 | Ethicon Llc | Surgical instrument assembly comprising a flexible articulation system |
MX2017008108A (en) | 2014-12-18 | 2018-03-06 | Ethicon Llc | Surgical instrument with an anvil that is selectively movable about a discrete non-movable axis relative to a staple cartridge. |
US10321907B2 (en) | 2015-02-27 | 2019-06-18 | Ethicon Llc | System for monitoring whether a surgical instrument needs to be serviced |
US11154301B2 (en) | 2015-02-27 | 2021-10-26 | Cilag Gmbh International | Modular stapling assembly |
US10180463B2 (en) | 2015-02-27 | 2019-01-15 | Ethicon Llc | Surgical apparatus configured to assess whether a performance parameter of the surgical apparatus is within an acceptable performance band |
US9993258B2 (en) | 2015-02-27 | 2018-06-12 | Ethicon Llc | Adaptable surgical instrument handle |
JP2020121162A (en) | 2015-03-06 | 2020-08-13 | エシコン エルエルシーEthicon LLC | Time dependent evaluation of sensor data to determine stability element, creep element and viscoelastic element of measurement |
US10687806B2 (en) | 2015-03-06 | 2020-06-23 | Ethicon Llc | Adaptive tissue compression techniques to adjust closure rates for multiple tissue types |
US9993248B2 (en) | 2015-03-06 | 2018-06-12 | Ethicon Endo-Surgery, Llc | Smart sensors with local signal processing |
US10617412B2 (en) | 2015-03-06 | 2020-04-14 | Ethicon Llc | System for detecting the mis-insertion of a staple cartridge into a surgical stapler |
US9901342B2 (en) | 2015-03-06 | 2018-02-27 | Ethicon Endo-Surgery, Llc | Signal and power communication system positioned on a rotatable shaft |
US10548504B2 (en) | 2015-03-06 | 2020-02-04 | Ethicon Llc | Overlaid multi sensor radio frequency (RF) electrode system to measure tissue compression |
US10045776B2 (en) | 2015-03-06 | 2018-08-14 | Ethicon Llc | Control techniques and sub-processor contained within modular shaft with select control processing from handle |
US10441279B2 (en) | 2015-03-06 | 2019-10-15 | Ethicon Llc | Multiple level thresholds to modify operation of powered surgical instruments |
US9924961B2 (en) | 2015-03-06 | 2018-03-27 | Ethicon Endo-Surgery, Llc | Interactive feedback system for powered surgical instruments |
US9895148B2 (en) | 2015-03-06 | 2018-02-20 | Ethicon Endo-Surgery, Llc | Monitoring speed control and precision incrementing of motor for powered surgical instruments |
US10245033B2 (en) | 2015-03-06 | 2019-04-02 | Ethicon Llc | Surgical instrument comprising a lockable battery housing |
US9808246B2 (en) | 2015-03-06 | 2017-11-07 | Ethicon Endo-Surgery, Llc | Method of operating a powered surgical instrument |
US10213201B2 (en) | 2015-03-31 | 2019-02-26 | Ethicon Llc | Stapling end effector configured to compensate for an uneven gap between a first jaw and a second jaw |
CN108377643B (en) | 2015-05-29 | 2021-09-21 | 纪念斯隆凯特琳癌症中心 | Therapeutic methods for inducing nutrient deprivation of cancer cells by iron death using ultra-small nanoparticles |
US10368861B2 (en) | 2015-06-18 | 2019-08-06 | Ethicon Llc | Dual articulation drive system arrangements for articulatable surgical instruments |
US11058425B2 (en) | 2015-08-17 | 2021-07-13 | Ethicon Llc | Implantable layers for a surgical instrument |
JP6828018B2 (en) | 2015-08-26 | 2021-02-10 | エシコン エルエルシーEthicon LLC | Surgical staple strips that allow you to change the characteristics of staples and facilitate filling into cartridges |
US10357251B2 (en) | 2015-08-26 | 2019-07-23 | Ethicon Llc | Surgical staples comprising hardness variations for improved fastening of tissue |
MX2022006192A (en) | 2015-09-02 | 2022-06-16 | Ethicon Llc | Surgical staple configurations with camming surfaces located between portions supporting surgical staples. |
US10238390B2 (en) | 2015-09-02 | 2019-03-26 | Ethicon Llc | Surgical staple cartridges with driver arrangements for establishing herringbone staple patterns |
US10076326B2 (en) | 2015-09-23 | 2018-09-18 | Ethicon Llc | Surgical stapler having current mirror-based motor control |
US10238386B2 (en) | 2015-09-23 | 2019-03-26 | Ethicon Llc | Surgical stapler having motor control based on an electrical parameter related to a motor current |
US10085751B2 (en) | 2015-09-23 | 2018-10-02 | Ethicon Llc | Surgical stapler having temperature-based motor control |
US10363036B2 (en) | 2015-09-23 | 2019-07-30 | Ethicon Llc | Surgical stapler having force-based motor control |
US10327769B2 (en) | 2015-09-23 | 2019-06-25 | Ethicon Llc | Surgical stapler having motor control based on a drive system component |
US10105139B2 (en) | 2015-09-23 | 2018-10-23 | Ethicon Llc | Surgical stapler having downstream current-based motor control |
US10299878B2 (en) | 2015-09-25 | 2019-05-28 | Ethicon Llc | Implantable adjunct systems for determining adjunct skew |
US10980539B2 (en) | 2015-09-30 | 2021-04-20 | Ethicon Llc | Implantable adjunct comprising bonded layers |
US10327777B2 (en) | 2015-09-30 | 2019-06-25 | Ethicon Llc | Implantable layer comprising plastically deformed fibers |
US11890015B2 (en) | 2015-09-30 | 2024-02-06 | Cilag Gmbh International | Compressible adjunct with crossing spacer fibers |
US10285699B2 (en) | 2015-09-30 | 2019-05-14 | Ethicon Llc | Compressible adjunct |
US10368865B2 (en) | 2015-12-30 | 2019-08-06 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10292704B2 (en) | 2015-12-30 | 2019-05-21 | Ethicon Llc | Mechanisms for compensating for battery pack failure in powered surgical instruments |
US10265068B2 (en) | 2015-12-30 | 2019-04-23 | Ethicon Llc | Surgical instruments with separable motors and motor control circuits |
BR112018016098B1 (en) | 2016-02-09 | 2023-02-23 | Ethicon Llc | SURGICAL INSTRUMENT |
US11213293B2 (en) | 2016-02-09 | 2022-01-04 | Cilag Gmbh International | Articulatable surgical instruments with single articulation link arrangements |
US20170224332A1 (en) | 2016-02-09 | 2017-08-10 | Ethicon Endo-Surgery, Llc | Surgical instruments with non-symmetrical articulation arrangements |
US10258331B2 (en) | 2016-02-12 | 2019-04-16 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US11224426B2 (en) | 2016-02-12 | 2022-01-18 | Cilag Gmbh International | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10448948B2 (en) | 2016-02-12 | 2019-10-22 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10617413B2 (en) | 2016-04-01 | 2020-04-14 | Ethicon Llc | Closure system arrangements for surgical cutting and stapling devices with separate and distinct firing shafts |
US11064997B2 (en) | 2016-04-01 | 2021-07-20 | Cilag Gmbh International | Surgical stapling instrument |
US11179150B2 (en) | 2016-04-15 | 2021-11-23 | Cilag Gmbh International | Systems and methods for controlling a surgical stapling and cutting instrument |
US10405859B2 (en) | 2016-04-15 | 2019-09-10 | Ethicon Llc | Surgical instrument with adjustable stop/start control during a firing motion |
US11607239B2 (en) | 2016-04-15 | 2023-03-21 | Cilag Gmbh International | Systems and methods for controlling a surgical stapling and cutting instrument |
US10335145B2 (en) | 2016-04-15 | 2019-07-02 | Ethicon Llc | Modular surgical instrument with configurable operating mode |
US10357247B2 (en) | 2016-04-15 | 2019-07-23 | Ethicon Llc | Surgical instrument with multiple program responses during a firing motion |
US10492783B2 (en) | 2016-04-15 | 2019-12-03 | Ethicon, Llc | Surgical instrument with improved stop/start control during a firing motion |
US10426467B2 (en) | 2016-04-15 | 2019-10-01 | Ethicon Llc | Surgical instrument with detection sensors |
US10828028B2 (en) | 2016-04-15 | 2020-11-10 | Ethicon Llc | Surgical instrument with multiple program responses during a firing motion |
US10456137B2 (en) | 2016-04-15 | 2019-10-29 | Ethicon Llc | Staple formation detection mechanisms |
US20170296173A1 (en) | 2016-04-18 | 2017-10-19 | Ethicon Endo-Surgery, Llc | Method for operating a surgical instrument |
US10368867B2 (en) | 2016-04-18 | 2019-08-06 | Ethicon Llc | Surgical instrument comprising a lockout |
US11317917B2 (en) | 2016-04-18 | 2022-05-03 | Cilag Gmbh International | Surgical stapling system comprising a lockable firing assembly |
US10702270B2 (en) | 2016-06-24 | 2020-07-07 | Ethicon Llc | Stapling system for use with wire staples and stamped staples |
JP6957532B2 (en) | 2016-06-24 | 2021-11-02 | エシコン エルエルシーEthicon LLC | Staple cartridges including wire staples and punched staples |
USD847989S1 (en) | 2016-06-24 | 2019-05-07 | Ethicon Llc | Surgical fastener cartridge |
USD826405S1 (en) | 2016-06-24 | 2018-08-21 | Ethicon Llc | Surgical fastener |
USD850617S1 (en) | 2016-06-24 | 2019-06-04 | Ethicon Llc | Surgical fastener cartridge |
US10945727B2 (en) | 2016-12-21 | 2021-03-16 | Ethicon Llc | Staple cartridge with deformable driver retention features |
US10588631B2 (en) | 2016-12-21 | 2020-03-17 | Ethicon Llc | Surgical instruments with positive jaw opening features |
US10918385B2 (en) | 2016-12-21 | 2021-02-16 | Ethicon Llc | Surgical system comprising a firing member rotatable into an articulation state to articulate an end effector of the surgical system |
US11134942B2 (en) | 2016-12-21 | 2021-10-05 | Cilag Gmbh International | Surgical stapling instruments and staple-forming anvils |
US10993715B2 (en) | 2016-12-21 | 2021-05-04 | Ethicon Llc | Staple cartridge comprising staples with different clamping breadths |
JP7010956B2 (en) | 2016-12-21 | 2022-01-26 | エシコン エルエルシー | How to staple tissue |
MX2019007311A (en) | 2016-12-21 | 2019-11-18 | Ethicon Llc | Surgical stapling systems. |
US10695055B2 (en) | 2016-12-21 | 2020-06-30 | Ethicon Llc | Firing assembly comprising a lockout |
US20180168633A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Surgical stapling instruments and staple-forming anvils |
US20180168625A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Surgical stapling instruments with smart staple cartridges |
US10682138B2 (en) | 2016-12-21 | 2020-06-16 | Ethicon Llc | Bilaterally asymmetric staple forming pocket pairs |
US10856868B2 (en) | 2016-12-21 | 2020-12-08 | Ethicon Llc | Firing member pin configurations |
US10687810B2 (en) | 2016-12-21 | 2020-06-23 | Ethicon Llc | Stepped staple cartridge with tissue retention and gap setting features |
CN110099619B (en) | 2016-12-21 | 2022-07-15 | 爱惜康有限责任公司 | Lockout device for surgical end effector and replaceable tool assembly |
US11090048B2 (en) | 2016-12-21 | 2021-08-17 | Cilag Gmbh International | Method for resetting a fuse of a surgical instrument shaft |
US11419606B2 (en) | 2016-12-21 | 2022-08-23 | Cilag Gmbh International | Shaft assembly comprising a clutch configured to adapt the output of a rotary firing member to two different systems |
US11684367B2 (en) | 2016-12-21 | 2023-06-27 | Cilag Gmbh International | Stepped assembly having and end-of-life indicator |
US10959727B2 (en) | 2016-12-21 | 2021-03-30 | Ethicon Llc | Articulatable surgical end effector with asymmetric shaft arrangement |
US20180168615A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Method of deforming staples from two different types of staple cartridges with the same surgical stapling instrument |
US10973516B2 (en) | 2016-12-21 | 2021-04-13 | Ethicon Llc | Surgical end effectors and adaptable firing members therefor |
US20180168648A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Durability features for end effectors and firing assemblies of surgical stapling instruments |
US10568624B2 (en) | 2016-12-21 | 2020-02-25 | Ethicon Llc | Surgical instruments with jaws that are pivotable about a fixed axis and include separate and distinct closure and firing systems |
US10426471B2 (en) | 2016-12-21 | 2019-10-01 | Ethicon Llc | Surgical instrument with multiple failure response modes |
US10888322B2 (en) | 2016-12-21 | 2021-01-12 | Ethicon Llc | Surgical instrument comprising a cutting member |
US11559591B2 (en) | 2017-05-25 | 2023-01-24 | Memorial Sloan Kettering Cancer Center | Ultrasmall nanoparticles labeled with Zirconium-89 and methods thereof |
US10813639B2 (en) | 2017-06-20 | 2020-10-27 | Ethicon Llc | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on system conditions |
US10881399B2 (en) | 2017-06-20 | 2021-01-05 | Ethicon Llc | Techniques for adaptive control of motor velocity of a surgical stapling and cutting instrument |
US10327767B2 (en) | 2017-06-20 | 2019-06-25 | Ethicon Llc | Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation |
USD890784S1 (en) | 2017-06-20 | 2020-07-21 | Ethicon Llc | Display panel with changeable graphical user interface |
US11071554B2 (en) | 2017-06-20 | 2021-07-27 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on magnitude of velocity error measurements |
US11517325B2 (en) | 2017-06-20 | 2022-12-06 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured displacement distance traveled over a specified time interval |
US10390841B2 (en) | 2017-06-20 | 2019-08-27 | Ethicon Llc | Control of motor velocity of a surgical stapling and cutting instrument based on angle of articulation |
USD879808S1 (en) | 2017-06-20 | 2020-03-31 | Ethicon Llc | Display panel with graphical user interface |
US10368864B2 (en) | 2017-06-20 | 2019-08-06 | Ethicon Llc | Systems and methods for controlling displaying motor velocity for a surgical instrument |
US10646220B2 (en) | 2017-06-20 | 2020-05-12 | Ethicon Llc | Systems and methods for controlling displacement member velocity for a surgical instrument |
US11382638B2 (en) | 2017-06-20 | 2022-07-12 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified displacement distance |
US10881396B2 (en) | 2017-06-20 | 2021-01-05 | Ethicon Llc | Surgical instrument with variable duration trigger arrangement |
US11090046B2 (en) | 2017-06-20 | 2021-08-17 | Cilag Gmbh International | Systems and methods for controlling displacement member motion of a surgical stapling and cutting instrument |
US10624633B2 (en) | 2017-06-20 | 2020-04-21 | Ethicon Llc | Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument |
US10307170B2 (en) | 2017-06-20 | 2019-06-04 | Ethicon Llc | Method for closed loop control of motor velocity of a surgical stapling and cutting instrument |
USD879809S1 (en) | 2017-06-20 | 2020-03-31 | Ethicon Llc | Display panel with changeable graphical user interface |
US10888321B2 (en) | 2017-06-20 | 2021-01-12 | Ethicon Llc | Systems and methods for controlling velocity of a displacement member of a surgical stapling and cutting instrument |
US10980537B2 (en) | 2017-06-20 | 2021-04-20 | Ethicon Llc | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified number of shaft rotations |
US11653914B2 (en) | 2017-06-20 | 2023-05-23 | Cilag Gmbh International | Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument according to articulation angle of end effector |
US10779820B2 (en) | 2017-06-20 | 2020-09-22 | Ethicon Llc | Systems and methods for controlling motor speed according to user input for a surgical instrument |
US20210145985A1 (en) * | 2017-06-23 | 2021-05-20 | Memorial Sloan Kettering Cancer Center | Method of imaging in vivo tissues using nanoparticles comprising a reference dye and a sensor dye |
US11324503B2 (en) | 2017-06-27 | 2022-05-10 | Cilag Gmbh International | Surgical firing member arrangements |
US10772629B2 (en) | 2017-06-27 | 2020-09-15 | Ethicon Llc | Surgical anvil arrangements |
US10993716B2 (en) | 2017-06-27 | 2021-05-04 | Ethicon Llc | Surgical anvil arrangements |
US11266405B2 (en) | 2017-06-27 | 2022-03-08 | Cilag Gmbh International | Surgical anvil manufacturing methods |
US10856869B2 (en) | 2017-06-27 | 2020-12-08 | Ethicon Llc | Surgical anvil arrangements |
US20180368844A1 (en) | 2017-06-27 | 2018-12-27 | Ethicon Llc | Staple forming pocket arrangements |
USD851762S1 (en) | 2017-06-28 | 2019-06-18 | Ethicon Llc | Anvil |
US11246592B2 (en) | 2017-06-28 | 2022-02-15 | Cilag Gmbh International | Surgical instrument comprising an articulation system lockable to a frame |
US10716614B2 (en) | 2017-06-28 | 2020-07-21 | Ethicon Llc | Surgical shaft assemblies with slip ring assemblies with increased contact pressure |
USD869655S1 (en) | 2017-06-28 | 2019-12-10 | Ethicon Llc | Surgical fastener cartridge |
US11259805B2 (en) | 2017-06-28 | 2022-03-01 | Cilag Gmbh International | Surgical instrument comprising firing member supports |
US10903685B2 (en) | 2017-06-28 | 2021-01-26 | Ethicon Llc | Surgical shaft assemblies with slip ring assemblies forming capacitive channels |
USD854151S1 (en) | 2017-06-28 | 2019-07-16 | Ethicon Llc | Surgical instrument shaft |
US10211586B2 (en) | 2017-06-28 | 2019-02-19 | Ethicon Llc | Surgical shaft assemblies with watertight housings |
US11484310B2 (en) | 2017-06-28 | 2022-11-01 | Cilag Gmbh International | Surgical instrument comprising a shaft including a closure tube profile |
EP3420947B1 (en) | 2017-06-28 | 2022-05-25 | Cilag GmbH International | Surgical instrument comprising selectively actuatable rotatable couplers |
US11564686B2 (en) | 2017-06-28 | 2023-01-31 | Cilag Gmbh International | Surgical shaft assemblies with flexible interfaces |
US10765427B2 (en) | 2017-06-28 | 2020-09-08 | Ethicon Llc | Method for articulating a surgical instrument |
USD906355S1 (en) | 2017-06-28 | 2020-12-29 | Ethicon Llc | Display screen or portion thereof with a graphical user interface for a surgical instrument |
US11478242B2 (en) | 2017-06-28 | 2022-10-25 | Cilag Gmbh International | Jaw retainer arrangement for retaining a pivotable surgical instrument jaw in pivotable retaining engagement with a second surgical instrument jaw |
US10932772B2 (en) | 2017-06-29 | 2021-03-02 | Ethicon Llc | Methods for closed loop velocity control for robotic surgical instrument |
US11007022B2 (en) | 2017-06-29 | 2021-05-18 | Ethicon Llc | Closed loop velocity control techniques based on sensed tissue parameters for robotic surgical instrument |
US10898183B2 (en) | 2017-06-29 | 2021-01-26 | Ethicon Llc | Robotic surgical instrument with closed loop feedback techniques for advancement of closure member during firing |
US10398434B2 (en) | 2017-06-29 | 2019-09-03 | Ethicon Llc | Closed loop velocity control of closure member for robotic surgical instrument |
US10258418B2 (en) | 2017-06-29 | 2019-04-16 | Ethicon Llc | System for controlling articulation forces |
US11304695B2 (en) | 2017-08-03 | 2022-04-19 | Cilag Gmbh International | Surgical system shaft interconnection |
US11471155B2 (en) | 2017-08-03 | 2022-10-18 | Cilag Gmbh International | Surgical system bailout |
US11944300B2 (en) | 2017-08-03 | 2024-04-02 | Cilag Gmbh International | Method for operating a surgical system bailout |
USD917500S1 (en) | 2017-09-29 | 2021-04-27 | Ethicon Llc | Display screen or portion thereof with graphical user interface |
US11399829B2 (en) | 2017-09-29 | 2022-08-02 | Cilag Gmbh International | Systems and methods of initiating a power shutdown mode for a surgical instrument |
US10729501B2 (en) | 2017-09-29 | 2020-08-04 | Ethicon Llc | Systems and methods for language selection of a surgical instrument |
US10765429B2 (en) | 2017-09-29 | 2020-09-08 | Ethicon Llc | Systems and methods for providing alerts according to the operational state of a surgical instrument |
USD907648S1 (en) | 2017-09-29 | 2021-01-12 | Ethicon Llc | Display screen or portion thereof with animated graphical user interface |
US10796471B2 (en) | 2017-09-29 | 2020-10-06 | Ethicon Llc | Systems and methods of displaying a knife position for a surgical instrument |
US10743872B2 (en) | 2017-09-29 | 2020-08-18 | Ethicon Llc | System and methods for controlling a display of a surgical instrument |
USD907647S1 (en) | 2017-09-29 | 2021-01-12 | Ethicon Llc | Display screen or portion thereof with animated graphical user interface |
US11134944B2 (en) | 2017-10-30 | 2021-10-05 | Cilag Gmbh International | Surgical stapler knife motion controls |
US11090075B2 (en) | 2017-10-30 | 2021-08-17 | Cilag Gmbh International | Articulation features for surgical end effector |
US10842490B2 (en) | 2017-10-31 | 2020-11-24 | Ethicon Llc | Cartridge body design with force reduction based on firing completion |
US10779903B2 (en) | 2017-10-31 | 2020-09-22 | Ethicon Llc | Positive shaft rotation lock activated by jaw closure |
US20200383943A1 (en) | 2017-12-04 | 2020-12-10 | Memorial Sloan Kettering Cancer Center | Methods of cancer treatment via regulated ferroptosis |
US10966718B2 (en) | 2017-12-15 | 2021-04-06 | Ethicon Llc | Dynamic clamping assemblies with improved wear characteristics for use in connection with electromechanical surgical instruments |
US11071543B2 (en) | 2017-12-15 | 2021-07-27 | Cilag Gmbh International | Surgical end effectors with clamping assemblies configured to increase jaw aperture ranges |
US11006955B2 (en) | 2017-12-15 | 2021-05-18 | Ethicon Llc | End effectors with positive jaw opening features for use with adapters for electromechanical surgical instruments |
US10687813B2 (en) | 2017-12-15 | 2020-06-23 | Ethicon Llc | Adapters with firing stroke sensing arrangements for use in connection with electromechanical surgical instruments |
US10743875B2 (en) | 2017-12-15 | 2020-08-18 | Ethicon Llc | Surgical end effectors with jaw stiffener arrangements configured to permit monitoring of firing member |
US11033267B2 (en) | 2017-12-15 | 2021-06-15 | Ethicon Llc | Systems and methods of controlling a clamping member firing rate of a surgical instrument |
US10743874B2 (en) | 2017-12-15 | 2020-08-18 | Ethicon Llc | Sealed adapters for use with electromechanical surgical instruments |
US10869666B2 (en) | 2017-12-15 | 2020-12-22 | Ethicon Llc | Adapters with control systems for controlling multiple motors of an electromechanical surgical instrument |
US10779826B2 (en) | 2017-12-15 | 2020-09-22 | Ethicon Llc | Methods of operating surgical end effectors |
US11197670B2 (en) | 2017-12-15 | 2021-12-14 | Cilag Gmbh International | Surgical end effectors with pivotal jaws configured to touch at their respective distal ends when fully closed |
US10779825B2 (en) | 2017-12-15 | 2020-09-22 | Ethicon Llc | Adapters with end effector position sensing and control arrangements for use in connection with electromechanical surgical instruments |
US10828033B2 (en) | 2017-12-15 | 2020-11-10 | Ethicon Llc | Handheld electromechanical surgical instruments with improved motor control arrangements for positioning components of an adapter coupled thereto |
US10716565B2 (en) | 2017-12-19 | 2020-07-21 | Ethicon Llc | Surgical instruments with dual articulation drivers |
USD910847S1 (en) | 2017-12-19 | 2021-02-16 | Ethicon Llc | Surgical instrument assembly |
US10835330B2 (en) | 2017-12-19 | 2020-11-17 | Ethicon Llc | Method for determining the position of a rotatable jaw of a surgical instrument attachment assembly |
US11045270B2 (en) | 2017-12-19 | 2021-06-29 | Cilag Gmbh International | Robotic attachment comprising exterior drive actuator |
US11020112B2 (en) | 2017-12-19 | 2021-06-01 | Ethicon Llc | Surgical tools configured for interchangeable use with different controller interfaces |
US10729509B2 (en) | 2017-12-19 | 2020-08-04 | Ethicon Llc | Surgical instrument comprising closure and firing locking mechanism |
US11179152B2 (en) | 2017-12-21 | 2021-11-23 | Cilag Gmbh International | Surgical instrument comprising a tissue grasping system |
US11311290B2 (en) | 2017-12-21 | 2022-04-26 | Cilag Gmbh International | Surgical instrument comprising an end effector dampener |
US11076853B2 (en) | 2017-12-21 | 2021-08-03 | Cilag Gmbh International | Systems and methods of displaying a knife position during transection for a surgical instrument |
US11129680B2 (en) | 2017-12-21 | 2021-09-28 | Cilag Gmbh International | Surgical instrument comprising a projector |
US11666411B2 (en) | 2018-05-10 | 2023-06-06 | Memorial Sloan Kettering Cancer Center | Systems for augmented reality surgical and clinical visualization |
US11045192B2 (en) | 2018-08-20 | 2021-06-29 | Cilag Gmbh International | Fabricating techniques for surgical stapler anvils |
US10856870B2 (en) | 2018-08-20 | 2020-12-08 | Ethicon Llc | Switching arrangements for motor powered articulatable surgical instruments |
US11324501B2 (en) | 2018-08-20 | 2022-05-10 | Cilag Gmbh International | Surgical stapling devices with improved closure members |
US10779821B2 (en) | 2018-08-20 | 2020-09-22 | Ethicon Llc | Surgical stapler anvils with tissue stop features configured to avoid tissue pinch |
US10842492B2 (en) | 2018-08-20 | 2020-11-24 | Ethicon Llc | Powered articulatable surgical instruments with clutching and locking arrangements for linking an articulation drive system to a firing drive system |
US10912559B2 (en) | 2018-08-20 | 2021-02-09 | Ethicon Llc | Reinforced deformable anvil tip for surgical stapler anvil |
US11253256B2 (en) | 2018-08-20 | 2022-02-22 | Cilag Gmbh International | Articulatable motor powered surgical instruments with dedicated articulation motor arrangements |
USD914878S1 (en) | 2018-08-20 | 2021-03-30 | Ethicon Llc | Surgical instrument anvil |
US11207065B2 (en) | 2018-08-20 | 2021-12-28 | Cilag Gmbh International | Method for fabricating surgical stapler anvils |
US11083458B2 (en) | 2018-08-20 | 2021-08-10 | Cilag Gmbh International | Powered surgical instruments with clutching arrangements to convert linear drive motions to rotary drive motions |
US11039834B2 (en) | 2018-08-20 | 2021-06-22 | Cilag Gmbh International | Surgical stapler anvils with staple directing protrusions and tissue stability features |
US11291440B2 (en) | 2018-08-20 | 2022-04-05 | Cilag Gmbh International | Method for operating a powered articulatable surgical instrument |
US11147551B2 (en) | 2019-03-25 | 2021-10-19 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11696761B2 (en) | 2019-03-25 | 2023-07-11 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11147553B2 (en) | 2019-03-25 | 2021-10-19 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11172929B2 (en) | 2019-03-25 | 2021-11-16 | Cilag Gmbh International | Articulation drive arrangements for surgical systems |
US11648009B2 (en) | 2019-04-30 | 2023-05-16 | Cilag Gmbh International | Rotatable jaw tip for a surgical instrument |
US11426251B2 (en) | 2019-04-30 | 2022-08-30 | Cilag Gmbh International | Articulation directional lights on a surgical instrument |
US11253254B2 (en) | 2019-04-30 | 2022-02-22 | Cilag Gmbh International | Shaft rotation actuator on a surgical instrument |
US11903581B2 (en) | 2019-04-30 | 2024-02-20 | Cilag Gmbh International | Methods for stapling tissue using a surgical instrument |
US11432816B2 (en) | 2019-04-30 | 2022-09-06 | Cilag Gmbh International | Articulation pin for a surgical instrument |
US11452528B2 (en) | 2019-04-30 | 2022-09-27 | Cilag Gmbh International | Articulation actuators for a surgical instrument |
US11471157B2 (en) | 2019-04-30 | 2022-10-18 | Cilag Gmbh International | Articulation control mapping for a surgical instrument |
US11464601B2 (en) | 2019-06-28 | 2022-10-11 | Cilag Gmbh International | Surgical instrument comprising an RFID system for tracking a movable component |
US11291451B2 (en) | 2019-06-28 | 2022-04-05 | Cilag Gmbh International | Surgical instrument with battery compatibility verification functionality |
US11638587B2 (en) | 2019-06-28 | 2023-05-02 | Cilag Gmbh International | RFID identification systems for surgical instruments |
US11259803B2 (en) | 2019-06-28 | 2022-03-01 | Cilag Gmbh International | Surgical stapling system having an information encryption protocol |
US11553971B2 (en) | 2019-06-28 | 2023-01-17 | Cilag Gmbh International | Surgical RFID assemblies for display and communication |
US11478241B2 (en) | 2019-06-28 | 2022-10-25 | Cilag Gmbh International | Staple cartridge including projections |
US11224497B2 (en) | 2019-06-28 | 2022-01-18 | Cilag Gmbh International | Surgical systems with multiple RFID tags |
US11399837B2 (en) | 2019-06-28 | 2022-08-02 | Cilag Gmbh International | Mechanisms for motor control adjustments of a motorized surgical instrument |
US11426167B2 (en) | 2019-06-28 | 2022-08-30 | Cilag Gmbh International | Mechanisms for proper anvil attachment surgical stapling head assembly |
US11523822B2 (en) | 2019-06-28 | 2022-12-13 | Cilag Gmbh International | Battery pack including a circuit interrupter |
US11376098B2 (en) | 2019-06-28 | 2022-07-05 | Cilag Gmbh International | Surgical instrument system comprising an RFID system |
US11298127B2 (en) | 2019-06-28 | 2022-04-12 | Cilag GmbH Interational | Surgical stapling system having a lockout mechanism for an incompatible cartridge |
US11660163B2 (en) | 2019-06-28 | 2023-05-30 | Cilag Gmbh International | Surgical system with RFID tags for updating motor assembly parameters |
US11771419B2 (en) | 2019-06-28 | 2023-10-03 | Cilag Gmbh International | Packaging for a replaceable component of a surgical stapling system |
US11246678B2 (en) | 2019-06-28 | 2022-02-15 | Cilag Gmbh International | Surgical stapling system having a frangible RFID tag |
US11051807B2 (en) | 2019-06-28 | 2021-07-06 | Cilag Gmbh International | Packaging assembly including a particulate trap |
US11627959B2 (en) | 2019-06-28 | 2023-04-18 | Cilag Gmbh International | Surgical instruments including manual and powered system lockouts |
US11219455B2 (en) | 2019-06-28 | 2022-01-11 | Cilag Gmbh International | Surgical instrument including a lockout key |
US11497492B2 (en) | 2019-06-28 | 2022-11-15 | Cilag Gmbh International | Surgical instrument including an articulation lock |
US11684434B2 (en) | 2019-06-28 | 2023-06-27 | Cilag Gmbh International | Surgical RFID assemblies for instrument operational setting control |
US11298132B2 (en) | 2019-06-28 | 2022-04-12 | Cilag GmbH Inlernational | Staple cartridge including a honeycomb extension |
US11350938B2 (en) | 2019-06-28 | 2022-06-07 | Cilag Gmbh International | Surgical instrument comprising an aligned rfid sensor |
US11446029B2 (en) | 2019-12-19 | 2022-09-20 | Cilag Gmbh International | Staple cartridge comprising projections extending from a curved deck surface |
US11607219B2 (en) | 2019-12-19 | 2023-03-21 | Cilag Gmbh International | Staple cartridge comprising a detachable tissue cutting knife |
US11559304B2 (en) | 2019-12-19 | 2023-01-24 | Cilag Gmbh International | Surgical instrument comprising a rapid closure mechanism |
US11304696B2 (en) | 2019-12-19 | 2022-04-19 | Cilag Gmbh International | Surgical instrument comprising a powered articulation system |
US11464512B2 (en) | 2019-12-19 | 2022-10-11 | Cilag Gmbh International | Staple cartridge comprising a curved deck surface |
US11291447B2 (en) | 2019-12-19 | 2022-04-05 | Cilag Gmbh International | Stapling instrument comprising independent jaw closing and staple firing systems |
US11701111B2 (en) | 2019-12-19 | 2023-07-18 | Cilag Gmbh International | Method for operating a surgical stapling instrument |
US11931033B2 (en) | 2019-12-19 | 2024-03-19 | Cilag Gmbh International | Staple cartridge comprising a latch lockout |
US11844520B2 (en) | 2019-12-19 | 2023-12-19 | Cilag Gmbh International | Staple cartridge comprising driver retention members |
US11529137B2 (en) | 2019-12-19 | 2022-12-20 | Cilag Gmbh International | Staple cartridge comprising driver retention members |
US11234698B2 (en) | 2019-12-19 | 2022-02-01 | Cilag Gmbh International | Stapling system comprising a clamp lockout and a firing lockout |
US11529139B2 (en) | 2019-12-19 | 2022-12-20 | Cilag Gmbh International | Motor driven surgical instrument |
US11576672B2 (en) | 2019-12-19 | 2023-02-14 | Cilag Gmbh International | Surgical instrument comprising a closure system including a closure member and an opening member driven by a drive screw |
US11911032B2 (en) | 2019-12-19 | 2024-02-27 | Cilag Gmbh International | Staple cartridge comprising a seating cam |
US11504122B2 (en) | 2019-12-19 | 2022-11-22 | Cilag Gmbh International | Surgical instrument comprising a nested firing member |
USD967421S1 (en) | 2020-06-02 | 2022-10-18 | Cilag Gmbh International | Staple cartridge |
USD975278S1 (en) | 2020-06-02 | 2023-01-10 | Cilag Gmbh International | Staple cartridge |
USD975851S1 (en) | 2020-06-02 | 2023-01-17 | Cilag Gmbh International | Staple cartridge |
USD976401S1 (en) | 2020-06-02 | 2023-01-24 | Cilag Gmbh International | Staple cartridge |
USD966512S1 (en) | 2020-06-02 | 2022-10-11 | Cilag Gmbh International | Staple cartridge |
USD975850S1 (en) | 2020-06-02 | 2023-01-17 | Cilag Gmbh International | Staple cartridge |
USD974560S1 (en) | 2020-06-02 | 2023-01-03 | Cilag Gmbh International | Staple cartridge |
US20220031320A1 (en) | 2020-07-28 | 2022-02-03 | Cilag Gmbh International | Surgical instruments with flexible firing member actuator constraint arrangements |
US11452526B2 (en) | 2020-10-29 | 2022-09-27 | Cilag Gmbh International | Surgical instrument comprising a staged voltage regulation start-up system |
US11534259B2 (en) | 2020-10-29 | 2022-12-27 | Cilag Gmbh International | Surgical instrument comprising an articulation indicator |
USD980425S1 (en) | 2020-10-29 | 2023-03-07 | Cilag Gmbh International | Surgical instrument assembly |
US11717289B2 (en) | 2020-10-29 | 2023-08-08 | Cilag Gmbh International | Surgical instrument comprising an indicator which indicates that an articulation drive is actuatable |
US11931025B2 (en) | 2020-10-29 | 2024-03-19 | Cilag Gmbh International | Surgical instrument comprising a releasable closure drive lock |
US11844518B2 (en) | 2020-10-29 | 2023-12-19 | Cilag Gmbh International | Method for operating a surgical instrument |
US11517390B2 (en) | 2020-10-29 | 2022-12-06 | Cilag Gmbh International | Surgical instrument comprising a limited travel switch |
US11779330B2 (en) | 2020-10-29 | 2023-10-10 | Cilag Gmbh International | Surgical instrument comprising a jaw alignment system |
USD1013170S1 (en) | 2020-10-29 | 2024-01-30 | Cilag Gmbh International | Surgical instrument assembly |
US11896217B2 (en) | 2020-10-29 | 2024-02-13 | Cilag Gmbh International | Surgical instrument comprising an articulation lock |
US11617577B2 (en) | 2020-10-29 | 2023-04-04 | Cilag Gmbh International | Surgical instrument comprising a sensor configured to sense whether an articulation drive of the surgical instrument is actuatable |
US11849943B2 (en) | 2020-12-02 | 2023-12-26 | Cilag Gmbh International | Surgical instrument with cartridge release mechanisms |
US11627960B2 (en) | 2020-12-02 | 2023-04-18 | Cilag Gmbh International | Powered surgical instruments with smart reload with separately attachable exteriorly mounted wiring connections |
US11678882B2 (en) | 2020-12-02 | 2023-06-20 | Cilag Gmbh International | Surgical instruments with interactive features to remedy incidental sled movements |
US11737751B2 (en) | 2020-12-02 | 2023-08-29 | Cilag Gmbh International | Devices and methods of managing energy dissipated within sterile barriers of surgical instrument housings |
US11653920B2 (en) | 2020-12-02 | 2023-05-23 | Cilag Gmbh International | Powered surgical instruments with communication interfaces through sterile barrier |
US11890010B2 (en) | 2020-12-02 | 2024-02-06 | Cllag GmbH International | Dual-sided reinforced reload for surgical instruments |
US11744581B2 (en) | 2020-12-02 | 2023-09-05 | Cilag Gmbh International | Powered surgical instruments with multi-phase tissue treatment |
US11653915B2 (en) | 2020-12-02 | 2023-05-23 | Cilag Gmbh International | Surgical instruments with sled location detection and adjustment features |
US11944296B2 (en) | 2020-12-02 | 2024-04-02 | Cilag Gmbh International | Powered surgical instruments with external connectors |
US11751869B2 (en) | 2021-02-26 | 2023-09-12 | Cilag Gmbh International | Monitoring of multiple sensors over time to detect moving characteristics of tissue |
US11749877B2 (en) | 2021-02-26 | 2023-09-05 | Cilag Gmbh International | Stapling instrument comprising a signal antenna |
US11701113B2 (en) | 2021-02-26 | 2023-07-18 | Cilag Gmbh International | Stapling instrument comprising a separate power antenna and a data transfer antenna |
US11696757B2 (en) | 2021-02-26 | 2023-07-11 | Cilag Gmbh International | Monitoring of internal systems to detect and track cartridge motion status |
US11950779B2 (en) | 2021-02-26 | 2024-04-09 | Cilag Gmbh International | Method of powering and communicating with a staple cartridge |
US11793514B2 (en) | 2021-02-26 | 2023-10-24 | Cilag Gmbh International | Staple cartridge comprising sensor array which may be embedded in cartridge body |
US11812964B2 (en) | 2021-02-26 | 2023-11-14 | Cilag Gmbh International | Staple cartridge comprising a power management circuit |
US11723657B2 (en) | 2021-02-26 | 2023-08-15 | Cilag Gmbh International | Adjustable communication based on available bandwidth and power capacity |
US11925349B2 (en) | 2021-02-26 | 2024-03-12 | Cilag Gmbh International | Adjustment to transfer parameters to improve available power |
US11950777B2 (en) | 2021-02-26 | 2024-04-09 | Cilag Gmbh International | Staple cartridge comprising an information access control system |
US11730473B2 (en) | 2021-02-26 | 2023-08-22 | Cilag Gmbh International | Monitoring of manufacturing life-cycle |
US11744583B2 (en) | 2021-02-26 | 2023-09-05 | Cilag Gmbh International | Distal communication array to tune frequency of RF systems |
US11737749B2 (en) | 2021-03-22 | 2023-08-29 | Cilag Gmbh International | Surgical stapling instrument comprising a retraction system |
US11759202B2 (en) | 2021-03-22 | 2023-09-19 | Cilag Gmbh International | Staple cartridge comprising an implantable layer |
US11723658B2 (en) | 2021-03-22 | 2023-08-15 | Cilag Gmbh International | Staple cartridge comprising a firing lockout |
US11717291B2 (en) | 2021-03-22 | 2023-08-08 | Cilag Gmbh International | Staple cartridge comprising staples configured to apply different tissue compression |
US11826012B2 (en) | 2021-03-22 | 2023-11-28 | Cilag Gmbh International | Stapling instrument comprising a pulsed motor-driven firing rack |
US11826042B2 (en) | 2021-03-22 | 2023-11-28 | Cilag Gmbh International | Surgical instrument comprising a firing drive including a selectable leverage mechanism |
US11806011B2 (en) | 2021-03-22 | 2023-11-07 | Cilag Gmbh International | Stapling instrument comprising tissue compression systems |
US11849944B2 (en) | 2021-03-24 | 2023-12-26 | Cilag Gmbh International | Drivers for fastener cartridge assemblies having rotary drive screws |
US11849945B2 (en) | 2021-03-24 | 2023-12-26 | Cilag Gmbh International | Rotary-driven surgical stapling assembly comprising eccentrically driven firing member |
US11903582B2 (en) | 2021-03-24 | 2024-02-20 | Cilag Gmbh International | Leveraging surfaces for cartridge installation |
US11896219B2 (en) | 2021-03-24 | 2024-02-13 | Cilag Gmbh International | Mating features between drivers and underside of a cartridge deck |
US11786239B2 (en) | 2021-03-24 | 2023-10-17 | Cilag Gmbh International | Surgical instrument articulation joint arrangements comprising multiple moving linkage features |
US11832816B2 (en) | 2021-03-24 | 2023-12-05 | Cilag Gmbh International | Surgical stapling assembly comprising nonplanar staples and planar staples |
US11786243B2 (en) | 2021-03-24 | 2023-10-17 | Cilag Gmbh International | Firing members having flexible portions for adapting to a load during a surgical firing stroke |
US11793516B2 (en) | 2021-03-24 | 2023-10-24 | Cilag Gmbh International | Surgical staple cartridge comprising longitudinal support beam |
US11944336B2 (en) | 2021-03-24 | 2024-04-02 | Cilag Gmbh International | Joint arrangements for multi-planar alignment and support of operational drive shafts in articulatable surgical instruments |
US11744603B2 (en) | 2021-03-24 | 2023-09-05 | Cilag Gmbh International | Multi-axis pivot joints for surgical instruments and methods for manufacturing same |
US11857183B2 (en) | 2021-03-24 | 2024-01-02 | Cilag Gmbh International | Stapling assembly components having metal substrates and plastic bodies |
US11896218B2 (en) | 2021-03-24 | 2024-02-13 | Cilag Gmbh International | Method of using a powered stapling device |
US11826047B2 (en) | 2021-05-28 | 2023-11-28 | Cilag Gmbh International | Stapling instrument comprising jaw mounts |
US11877745B2 (en) | 2021-10-18 | 2024-01-23 | Cilag Gmbh International | Surgical stapling assembly having longitudinally-repeating staple leg clusters |
US11937816B2 (en) | 2021-10-28 | 2024-03-26 | Cilag Gmbh International | Electrical lead arrangements for surgical instruments |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4275300A (en) * | 1978-10-23 | 1981-06-23 | Varian Associates, Inc. | Fluorescent composition, a process for synthesizing the fluorescent composition, and methods of use of the fluorescent composition |
GB2045431B (en) * | 1979-02-26 | 1983-04-20 | Technicon Instr | Immunoassay utilising two particulate reagents |
US4812409A (en) * | 1986-01-31 | 1989-03-14 | Eastman Kodak Company | Hydrolyzable fluorescent substrates and analytical determinations using same |
US4810636A (en) * | 1986-12-09 | 1989-03-07 | Miles Inc. | Chromogenic acridinone enzyme substrates |
US4774339A (en) * | 1987-08-10 | 1988-09-27 | Molecular Probes, Inc. | Chemically reactive dipyrrometheneboron difluoride dyes |
US4957487A (en) * | 1988-12-30 | 1990-09-18 | Baylor College Of Medicine | External male urinary catheter and collection system |
DE9010130U1 (en) * | 1989-07-13 | 1990-09-13 | American Medical Systems, Inc., Minnetonka, Minn., Us | |
US5274113A (en) * | 1991-11-01 | 1993-12-28 | Molecular Probes, Inc. | Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates |
US5433896A (en) * | 1994-05-20 | 1995-07-18 | Molecular Probes, Inc. | Dibenzopyrrometheneboron difluoride dyes |
US5248782A (en) * | 1990-12-18 | 1993-09-28 | Molecular Probes, Inc. | Long wavelength heteroaryl-substituted dipyrrometheneboron difluoride dyes |
US5187288A (en) * | 1991-05-22 | 1993-02-16 | Molecular Probes, Inc. | Ethenyl-substituted dipyrrometheneboron difluoride dyes and their synthesis |
US5409666A (en) * | 1991-08-08 | 1995-04-25 | Minnesota Mining And Manufacturing Company | Sensors and methods for sensing |
JP2507204B2 (en) * | 1991-08-30 | 1996-06-12 | 松下電器産業株式会社 | Video signal encoder |
US5639603A (en) * | 1991-09-18 | 1997-06-17 | Affymax Technologies N.V. | Synthesizing and screening molecular diversity |
US5260957A (en) * | 1992-10-29 | 1993-11-09 | The Charles Stark Draper Laboratory, Inc. | Quantum dot Laser |
DE69519384T2 (en) | 1994-09-29 | 2001-05-23 | British Telecomm | Optical fiber with quantum dots |
US6228873B1 (en) * | 1994-12-09 | 2001-05-08 | The Regents Of The University Of California | Method for enhancing outflow of aqueous humor in treatment of glaucoma |
US5981180A (en) * | 1995-10-11 | 1999-11-09 | Luminex Corporation | Multiplexed analysis of clinical specimens apparatus and methods |
US5830912A (en) * | 1996-11-15 | 1998-11-03 | Molecular Probes, Inc. | Derivatives of 6,8-difluoro-7-hydroxycoumarin |
US6180415B1 (en) * | 1997-02-20 | 2001-01-30 | The Regents Of The University Of California | Plasmon resonant particles, methods and apparatus |
US6344272B1 (en) * | 1997-03-12 | 2002-02-05 | Wm. Marsh Rice University | Metal nanoshells |
US6322901B1 (en) * | 1997-11-13 | 2001-11-27 | Massachusetts Institute Of Technology | Highly luminescent color-selective nano-crystalline materials |
US5990479A (en) * | 1997-11-25 | 1999-11-23 | Regents Of The University Of California | Organo Luminescent semiconductor nanocrystal probes for biological applications and process for making and using such probes |
US6207392B1 (en) * | 1997-11-25 | 2001-03-27 | The Regents Of The University Of California | Semiconductor nanocrystal probes for biological applications and process for making and using such probes |
ATE239801T1 (en) * | 1998-01-22 | 2003-05-15 | Luminex Corp | MICROPARTICLES WITH MULTIPLE FLUORESCENCE SIGNALS |
US6428811B1 (en) * | 1998-03-11 | 2002-08-06 | Wm. Marsh Rice University | Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery |
EP1064088B1 (en) * | 1998-03-19 | 2002-12-04 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Fabrication of multilayer-coated particles and hollow shells via electrostatic self-assembly of nanocomposite multilayers on decomposable colloidal templates |
US6501091B1 (en) | 1998-04-01 | 2002-12-31 | Massachusetts Institute Of Technology | Quantum dot white and colored light emitting diodes |
US6306610B1 (en) * | 1998-09-18 | 2001-10-23 | Massachusetts Institute Of Technology | Biological applications of quantum dots |
US6426513B1 (en) * | 1998-09-18 | 2002-07-30 | Massachusetts Institute Of Technology | Water-soluble thiol-capped nanocrystals |
US6326144B1 (en) * | 1998-09-18 | 2001-12-04 | Massachusetts Institute Of Technology | Biological applications of quantum dots |
US6251303B1 (en) * | 1998-09-18 | 2001-06-26 | Massachusetts Institute Of Technology | Water-soluble fluorescent nanocrystals |
US6454789B1 (en) * | 1999-01-15 | 2002-09-24 | Light Science Corporation | Patient portable device for photodynamic therapy |
AU4701200A (en) * | 1999-05-07 | 2000-11-21 | Quantum Dot Corporation | A method of detecting an analyte using semiconductor nanocrystals |
US20060293695A1 (en) * | 1999-07-20 | 2006-12-28 | Ricci Donald R | Bifurcated stent delivery system and method of use |
EP2365096A1 (en) * | 2000-03-22 | 2011-09-14 | Life Technologies Corporation | Methods of using semiconductor nanocrystals in bead-based nucleic acid assays |
US6548264B1 (en) * | 2000-05-17 | 2003-04-15 | University Of Florida | Coated nanoparticles |
US6554841B1 (en) * | 2000-09-22 | 2003-04-29 | Scimed Life Systems, Inc. | Striped sleeve for stent delivery |
US6649138B2 (en) * | 2000-10-13 | 2003-11-18 | Quantum Dot Corporation | Surface-modified semiconductive and metallic nanoparticles having enhanced dispersibility in aqueous media |
ATE556845T1 (en) * | 2001-07-20 | 2012-05-15 | Life Technologies Corp | LUMINESCENT NANOPARTICLES AND THEIR PRODUCTION |
US6890719B2 (en) | 2002-05-10 | 2005-05-10 | The Board Of Trustess Of The University Of Illinois | Fluorescence based biosensor |
US20040101822A1 (en) * | 2002-11-26 | 2004-05-27 | Ulrich Wiesner | Fluorescent silica-based nanoparticles |
US20080033570A1 (en) * | 2003-08-01 | 2008-02-07 | Blitz Benjamin T | Prostatic stent placement device |
JP4443278B2 (en) * | 2004-03-26 | 2010-03-31 | テルモ株式会社 | Catheter with expansion body |
US20060178721A1 (en) * | 2005-02-10 | 2006-08-10 | Advanced Cardiovascular Systems, Inc. | Stent delivery balloon catheter having improved stent retention |
-
2005
- 2005-05-02 US US11/119,969 patent/US8084001B2/en active Active
-
2006
- 2006-04-28 JP JP2008510082A patent/JP2008540308A/en active Pending
- 2006-04-28 WO PCT/US2006/016389 patent/WO2006119087A2/en active Application Filing
- 2006-04-28 CN CN2006800217500A patent/CN101198672B/en active Active
- 2006-04-28 EP EP06769923.1A patent/EP1877772B1/en active Active
Non-Patent Citations (1)
Title |
---|
See references of EP1877772A4 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8961825B2 (en) | 2009-04-15 | 2015-02-24 | Cornell University | Fluorescent silica nanoparticles through silica densification |
WO2012052068A1 (en) * | 2010-10-22 | 2012-04-26 | University College Cork, National University Of Ireland, Cork | Method and probe for monitoring oxygen status in live mammalian cells |
US10508992B2 (en) | 2010-10-22 | 2019-12-17 | University College Cork, National University of Ir Cork | Method and probe for monitoring oxygen status in live mammalian cells |
US11744897B2 (en) | 2020-10-27 | 2023-09-05 | Elucida Oncology, Inc. | Folate receptor targeted nanoparticle drug conjugates and uses thereof |
US11957760B2 (en) | 2023-03-14 | 2024-04-16 | Elucida Oncology, Inc. | Folate receptor targeted nanoparticle drug conjugates and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
EP1877772B1 (en) | 2015-06-03 |
CN101198672A (en) | 2008-06-11 |
US8084001B2 (en) | 2011-12-27 |
US20060245971A1 (en) | 2006-11-02 |
EP1877772A2 (en) | 2008-01-16 |
EP1877772A4 (en) | 2009-05-27 |
WO2006119087A3 (en) | 2007-10-18 |
CN101198672B (en) | 2012-09-05 |
JP2008540308A (en) | 2008-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8084001B2 (en) | Photoluminescent silica-based sensors and methods of use | |
Bigdeli et al. | Ratiometric fluorescent nanoprobes for visual detection: Design principles and recent advances-A review | |
US20200150120A1 (en) | Portable electronic device, system, and method for analyte detection | |
Gorris et al. | Perspectives and challenges of photon-upconversion nanoparticles-Part II: bioanalytical applications | |
Goryacheva et al. | Nanosized labels for rapid immunotests | |
Baù et al. | Sensing with fluorescent nanoparticles | |
Kumar et al. | Recent trends in the developments of analytical probes based on lanthanide-doped upconversion nanoparticles | |
Gonzalez et al. | Silicon nanocrystals for the development of sensing platforms | |
Doussineau et al. | On the design of fluorescent ratiometric nanosensors | |
Clapp et al. | Förster resonance energy transfer investigations using quantum‐dot fluorophores | |
Schäferling | Nanoparticle‐based luminescent probes for intracellular sensing and imaging of pH | |
Christ et al. | Chemical sensing and imaging based on photon upconverting nano-and microcrystals: a review | |
Jenie et al. | Recent advances on luminescent enhancement-based porous silicon biosensors | |
Yang et al. | FRET-created traffic light immunoassay based on polymer dots for PSA detection | |
Ruedas-Rama et al. | A chloride ion nanosensor for time-resolved fluorimetry and fluorescence lifetime imaging | |
US7807265B2 (en) | Partially passivated quantum dots, process for making, and sensors therefrom | |
Viger et al. | Reduction of self-quenching in fluorescent silica-coated silver nanoparticles | |
Deng et al. | Chemical sensing with nanoparticles as optical reporters: from noble metal nanoparticles to quantum dots and upconverting nanoparticles | |
WO2010121066A2 (en) | Silica nanoparticles incorporating chemiluminescent and absorbing active molecules | |
JP6141186B2 (en) | Multiple dye-doped silica nanoparticles featuring highly efficient energy transfer and tunable stalk shift | |
Seo et al. | Single-photon-driven up-/down-conversion nanohybrids for in vivo mercury detection and real-time tracking | |
Schäferling et al. | Luminescent nanoparticles for chemical sensing and imaging | |
Zhang et al. | A time-resolved ratiometric luminescent anthrax biomarker nanosensor based on an Ir (iii) complex-doped coordination polymer network | |
JP5540867B2 (en) | Organic fluorescent dye-encapsulated silica nanoparticles, method for producing the same, and biomaterial labeling agent using the same | |
CN107421938B (en) | A kind of SiO detecting malachite green2The preparation method of@ROX nanoparticle fluorescence probe array |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680021750.0 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2006769923 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2008510082 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |